ANTIMICROBIAL|ANTIMICROBIAL|NNP AGENTS|agent|NNS AND|and|CC CHEMOTHERAPY|chemotherapy|NN ,|,|, June|June|NNP 2009|2009|CD ,|,|, p.|p.|NN 2298|2298|CD --|--|: 2305 0066-4804|2305 0066-4804|NN /|/|HYPH 09|09|CD /|/|SYM $|$|$ 08.00|08.00|CD 0|0|CD doi|doi|NN :|:|: 10.1128|10.1128|CD /|/|SYM AAC.01016|aac.01016|NN -|-|HYPH 08|08|CD Copyright|copyright|NN ©|©|SYM 2009|2009|CD ,|,|, American|American|NNP Society|Society|NNP for|for|IN Microbiology|Microbiology|NNP .|.|. 
All|all|DT Rights|Rights|NNPS Reserved|Reserved|NNP .|.|. 
Genetic|genetic|JJ A|a|NN nalysis|nalysis|NN of|of|IN Colistin|Colistin|NNP Resistance|Resistance|NNP in|in|IN Salmonella|Salmonella|NNP enterica|enterica|NNP Serovar|Serovar|NNP Typhimurium|Typhimurium|NNP †|†|SYM Song|Song|NNP Sun|Sun|NNP ,1|,1|NNP Aurel|Aurel|NNP Negrea|Negrea|NNP ,2|,2|NN Mikael|Mikael|NNP Rhen|Rhen|NNP ,2|,2|NN and|and|CC Dan|Dan|NNP I.|I.|NNP Andersson1|andersson1|NN *|*|NFP Department|Department|NNP of|of|IN Medical|Medical|NNP Biochemistry|Biochemistry|NNP and|and|CC Microbiology|Microbiology|NNP ,|,|, Uppsala|Uppsala|NNP University|University|NNP ,|,|, S|s|NN -|-|HYPH 751|751|CD 23|23|CD Uppsala|Uppsala|NNP ,|,|, Sweden|Sweden|NNP ,1|,1|NN and|and|CC Microbiology|Microbiology|NNP and|and|CC Tumor|Tumor|NNP Biology|Biology|NNP Centre|Centre|NNP ,|,|, Karolinska|Karolinska|NNP Institute|Institute|NNP ,|,|, S|S|NNP -|-|HYPH 171|171|CD 82|82|CD Solna|Solna|NNP ,|,|, Sweden2|Sweden2|NNP Received|receive|VBD 29|29|CD July|July|NNP 2008|2008|CD /|/|SYM Returned|Returned|NNP for|for|IN modiﬁcation|modiﬁcation|NN 29|29|CD September|September|NNP 2008|2008|CD /|/|SYM Accepted|accepted|JJ 23|23|CD March|March|NNP 2009|2009|CD Colistin|Colistin|NNP is|be|VBZ a|a|DT cyclic|cyclic|JJ cationic|cationic|JJ peptide|peptide|NN that|that|WDT kills|kill|VBZ gram|gram|NN -|-|HYPH negative|negative|JJ bacteria|bacterium|NNS by|by|IN interacting|interact|VBG with|with|IN and|and|CC disrupting|disrupt|VBG the|the|DT outer|outer|JJ membrane|membrane|NN .|.|. 
We|we|PRP isolated|isolate|VBD 44|44|CD independent|independent|JJ mutants|mutant|NNS in|in|IN Salmonella|Salmonella|NNP enterica|enterica|NNP serovar|serovar|NNP Typhimurium|Typhimurium|NNP with|with|IN reduced|reduce|VBN susceptibility|susceptibility|NN to|to|IN colistin|colistin|NN and|and|CC identiﬁed|identiﬁed|VBN 27|27|CD different|different|JJ missense|missense|NN mutations|mutation|NNS located|locate|VBN in|in|IN the|the|DT pmrA|pmra|NN and|and|CC pmrB|pmrb|NN genes|gene|NNS (|(|-LRB- encoding|encode|VBG the|the|DT regulator|regulator|NN and|and|CC sensor|sensor|NN of|of|IN a|a|DT two|two|CD -|-|HYPH component|component|NN regulatory|regulatory|JJ system|system|NN )|)|-RRB- that|that|WDT conferred|confer|VBD increased|increase|VBN resistance|resistance|NN .|.|. 
By|by|IN comparison|comparison|NN of|of|IN the|the|DT two|two|CD homologous|homologous|JJ sensor|sensor|NN kinases|kinase|NNS ,|,|, PmrB|pmrb|NN and|and|CC EnvZ|envz|NN ,|,|, the|the|DT 22|22|CD missense|missense|NN mutations|mutation|NNS identiﬁed|identiﬁed|VBN in|in|IN pmrB|pmrb|NN were|be|VBD shown|show|VBN to|to|TO be|be|VB located|locate|VBN in|in|IN four|four|CD different|different|JJ structural|structural|JJ domains|domain|NNS of|of|IN the|the|DT protein|protein|NN .|.|. 
All|all|DT ﬁve|ﬁve|NN pmrA|pmra|NN mutations|mutation|NNS were|be|VBD located|locate|VBN in|in|IN the|the|DT phosphate|phosphate|NN receiver|receiver|NN domain|domain|NN of|of|IN the|the|DT regulator|regulator|NN protein|protein|NN .|.|. 
The|the|DT mutants|mutant|NNS appeared|appear|VBD at|at|IN a|a|DT mutation|mutation|NN rate|rate|NN of|of|IN 0.6|0.6|CD 10|10|CD 6|6|CD per|per|IN cell|cell|NN per|per|IN generation|generation|NN .|.|. 
The|the|DT MICs|mic|NNS of|of|IN colistin|colistin|NN for|for|IN the|the|DT mutants|mutant|NNS increased|increase|VBD 2|2|CD -|-|HYPH to|to|IN 35-fold|35-fold|RB ,|,|, and|and|CC the|the|DT extent|extent|NN of|of|IN killing|killing|NN was|be|VBD reduced|reduce|VBN several|several|JJ orders|order|NNS of|of|IN magnitude|magnitude|NN compared|compare|VBN to|to|IN the|the|DT susceptible|susceptible|JJ strain|strain|NN .|.|. 
The|the|DT growth|growth|NN rates|rate|NNS of|of|IN the|the|DT mutants|mutant|NNS were|be|VBD slightly|slightly|RB reduced|reduce|VBN in|in|IN both|both|DT rich|rich|JJ medium|medium|NN and|and|CC M9|m9|NN -|-|HYPH glycerol|glycerol|NN minimal|minimal|JJ medium|medium|NN ,|,|, whereas|whereas|IN growth|growth|NN in|in|IN mice|mouse|NNS appeared|appear|VBD unaffected|unaffected|JJ by|by|IN the|the|DT pmrA|pmra|NN and|and|CC pmrB|pmrb|NN mutations|mutation|NNS .|.|. 
The|the|DT low|low|JJ ﬁtness|ﬁtness|NN costs|cost|NNS and|and|CC the|the|DT high|high|JJ mutation|mutation|NN rate|rate|NN suggest|suggest|VBP that|that|IN mutants|mutant|NNS with|with|IN reduced|reduce|VBN susceptibility|susceptibility|NN to|to|IN colistin|colistin|NN could|could|MD emerge|emerge|VB in|in|IN clinical|clinical|JJ settings|setting|NNS .|.|. 
Polymyxins|polymyxin|NNS (|(|-LRB- PMs|pm|NNS )|)|-RRB- constitute|constitute|VBP a|a|DT group|group|NN of|of|IN membrane|membrane|NN -|-|HYPH active|active|JJ polypeptide|polypeptide|NN antibiotics|antibiotic|NNS that|that|WDT is|be|VBZ comprised|comprise|VBN of|of|IN ﬁve|ﬁve|NN chemically|chemically|RB different|different|JJ compounds|compound|NNS (|(|-LRB- PMs|pm|NNS A|a|NN to|to|IN E|e|NN )|)|-RRB- (|(|-LRB- 34|34|CD )|)|-RRB- .|.|. 
Colistin|Colistin|NNP (|(|-LRB- PM|pm|NN E|e|NN )|)|-RRB- was|be|VBD discovered|discover|VBN in|in|IN 1949|1949|CD and|and|CC was|be|VBD later|later|RB cautiously|cautiously|RB used|use|VBN clinically|clinically|RB because|because|IN of|of|IN the|the|DT reported|report|VBN high|high|JJ incidence|incidence|NN of|of|IN nephrotoxicity|nephrotoxicity|NN (|(|-LRB- 14|14|CD )|)|-RRB- .|.|. 
However|however|RB ,|,|, the|the|DT emergence|emergence|NN of|of|IN multidrug|multidrug|JJ -|-|HYPH resistant|resistant|JJ gram|gram|NN -|-|HYPH negative|negative|JJ bacteria|bacterium|NNS and|and|CC the|the|DT serious|serious|JJ lack|lack|NN of|of|IN development|development|NN of|of|IN new|new|JJ antibiotics|antibiotic|NNS led|lead|VBD to|to|IN a|a|DT revival|revival|NN in|in|IN the|the|DT use|use|NN of|of|IN PMs|pm|NNS ,|,|, and|and|CC several|several|JJ recently|recently|RB published|publish|VBN studies|study|NNS and|and|CC case|case|NN reports|report|NNS have|have|VBP shown|show|VBN that|that|IN colistin|colistin|NN can|can|MD be|be|VB used|use|VBN safely|safely|RB and|and|CC effectively|effectively|RB with|with|IN minimal|minimal|JJ adverse|adverse|JJ outcomes|outcome|NNS (|(|-LRB- 12|12|CD ,|,|, 25|25|CD ,|,|, 29|29|CD )|)|-RRB- .|.|. 
Two|two|CD forms|form|NNS of|of|IN colistin|colistin|NN are|be|VBP available|available|JJ commercially|commercially|RB :|:|: colis|colis|NN -|-|HYPH tin|tin|NN sulfate|sulfate|NN and|and|CC sodium|sodium|NN colistin|colistin|NN methanesulfonate|methanesulfonate|NN .|.|. 
The|the|DT predominant|predominant|JJ use|use|NN of|of|IN these|these|DT drugs|drug|NNS over|over|IN the|the|DT last|last|JJ 20|20|CD years|year|NNS has|have|VBZ been|be|VBN for|for|IN inhalational|inhalational|JJ treatment|treatment|NN of|of|IN Pseudomonas|Pseudomonas|NNP aeruginosa|aeruginosa|NNP infections|infection|NNS in|in|IN cystic|cystic|JJ ﬁbrosis|ﬁbrosis|NN patients|patient|NNS (|(|-LRB- 10|10|CD )|)|-RRB- .|.|. 
Recently|recently|RB ,|,|, there|there|EX have|have|VBP been|be|VBN several|several|JJ clinical|clinical|JJ reports|report|NNS on|on|IN the|the|DT efﬁcacy|efﬁcacy|NN of|of|IN intravenous|intravenous|JJ colistin|colistin|NN methanesulfonate|methanesulfonate|NN in|in|IN patients|patient|NNS with|with|IN infections|infection|NNS by|by|IN different|different|JJ types|type|NNS of|of|IN gramnegative|gramnegative|JJ bacteria|bacterium|NNS (|(|-LRB- 17|17|CD ,|,|, 19|19|CD )|)|-RRB- .|.|. 
Most|most|JJS attention|attention|NN has|have|VBZ been|be|VBN focused|focus|VBN on|on|IN multiresistant|multiresistant|JJ strains|strain|NNS of|of|IN P.|P.|NNP aeruginosa|aeruginosa|NNP and|and|CC Acinetobacter|Acinetobacter|NNP baumannii|baumannii|NNP ,|,|, but|but|CC colistin|colistin|NN is|be|VBZ also|also|RB used|use|VBN for|for|IN the|the|DT treatment|treatment|NN of|of|IN Klebsiella|klebsiella|NN pneumoniae|pneumonia|NNS and|and|CC Enterobacter|enterobacter|NN cloacae|cloaca|NNS infections|infection|NNS (|(|-LRB- 11|11|CD ,|,|, 35|35|CD )|)|-RRB- .|.|. 
Colistin|colistin|NN targets|target|VBZ the|the|DT cell|cell|NN envelope|envelope|NN ,|,|, and|and|CC the|the|DT interaction|interaction|NN between|between|IN the|the|DT cationic|cationic|JJ polypeptide|polypeptide|NN and|and|CC negatively|negatively|RB charged|charge|VBN lipo|lipo|NN -|-|HYPH polysaccharides|polysaccharide|NNS (|(|-LRB- LPS|lps|NN )|)|-RRB- leads|lead|VBZ to|to|IN a|a|DT disturbance|disturbance|NN of|of|IN the|the|DT outer|outer|JJ membrane|membrane|NN and|and|CC a|a|DT subsequent|subsequent|JJ increase|increase|NN in|in|IN the|the|DT permeability|permeability|NN of|of|IN the|the|DT cell|cell|NN envelope|envelope|NN that|that|WDT ultimately|ultimately|RB results|result|VBZ in|in|IN death|death|NN (|(|-LRB- 21|21|CD ,|,|, 30|30|CD )|)|-RRB- .|.|. 
In|in|IN *|*|NFP Corresponding|correspond|VBG author|author|NN .|.|. 
Mailing|mail|VBG address|address|NN :|:|: Uppsala|Uppsala|NNP University|University|NNP ,|,|, Bacteriology|Bacteriology|NNP ,|,|, BMC|bmc|NN ,|,|, Box|Box|NNP 582|582|CD ,|,|, IMBIM|IMBIM|NNP ,|,|, Uppsala|Uppsala|NNP 75123|75123|CD ,|,|, Sweden|Sweden|NNP .|.|. 
Phone|phone|NN :|:|: 46 18 4714175|46 18 4714175|CD .|.|. 
Fax|fax|NN :|:|: 46 18 4714673|46 18 4714673|CD .|.|. 
E-mail|e-mail|NN :|:|: Dan.Andersson|Dan.Andersson|NNP @imbim|@imbim|NNP .|.|. 
uu.se|uu.se|JJ .|.|. 
†|†|NFP Supplemental|supplemental|NN material|material|NN for|for|IN this|this|DT article|article|NN may|may|MD be|be|VB found|find|VBN at|at|IN http://aac|http://aac|ADD .|.|. 
asm.org|asm.org|NN /|/|HYPH .|.|. 
Published|publish|VBN ahead|ahead|RB of|of|IN print|print|NN on|on|IN 30|30|CD March|March|NNP 2009|2009|CD .|.|. 
vitro|vitro|FW studies|study|NNS of|of|IN PM|pm|NN -|-|HYPH resistant|resistant|JJ mutants|mutant|NNS of|of|IN Salmonella|Salmonella|NNP enterica|enterica|NNP serovar|serovar|NNP Typhimurium|Typhimurium|NNP have|have|VBP shown|show|VBN that|that|IN the|the|DT resistance|resistance|NN is|be|VBZ primarily|primarily|RB caused|cause|VBN by|by|IN decreased|decrease|VBN binding|binding|NN of|of|IN PM|pm|NN to|to|IN the|the|DT mutant|mutant|NN LPS|lps|NN (|(|-LRB- 37|37|CD )|)|-RRB- .|.|. 
Mutations|mutation|NNS conferring|confer|VBG colistin|colistin|NN resistance|resistance|NN on|on|IN S.|S.|NNP Typhimurium|Typhimurium|NNP were|be|VBD mapped|map|VBN to|to|IN a|a|DT locus|locus|NN named|name|VBN pmrA|pmra|NN (|(|-LRB- 18|18|CD )|)|-RRB- .|.|. 
In|in|IN S.|S.|NNP Typhimurium|Typhimurium|NNP ,|,|, P.|P.|NNP aeruginosa|aeruginosa|NNP ,|,|, and|and|CC A.|A.|NNP baumannii|baumannii|NNP ,|,|, two|two|CD genes|gene|NNS ,|,|, pmrA|pmra|NN and|and|CC pmrB|pmrb|NN ,|,|, were|be|VBD identiﬁed|identiﬁed|VBN and|and|CC shown|show|VBN to|to|TO constitute|constitute|VB a|a|DT two|two|CD -|-|HYPH component|component|NN regulatory|regulatory|JJ system|system|NN that|that|WDT is|be|VBZ responsible|responsible|JJ for|for|IN PM|pm|NN resistance|resistance|NN in|in|IN all|all|DT three|three|CD species|species|NNS (|(|-LRB- 1|1|CD ,|,|, 20|20|CD ,|,|, 28|28|CD )|)|-RRB- .|.|. 
This|this|DT similarity|similarity|NN implies|imply|VBZ that|that|IN studies|study|NNS of|of|IN the|the|DT genetically|genetically|RB amenable|amenable|JJ species|species|NNS S.|S.|NNP Typhimurium|Typhimurium|NNP could|could|MD be|be|VB applicable|applicable|JJ to|to|IN the|the|DT clinically|clinically|RB relevant|relevant|JJ species|species|NNS P.|P.|NNP aeruginosa|aeruginosa|NNP and|and|CC A.|A.|NNP baumannii|baumannii|NNP .|.|. 
PmrB|pmrb|NN is|be|VBZ a|a|DT sensor|sensor|NN histidine|histidine|NN kinase|kinase|NN ,|,|, and|and|CC PmrA|pmra|NN is|be|VBZ the|the|DT cognate|cognate|JJ response|response|NN regulator|regulator|NN .|.|. 
The|the|DT activity|activity|NN of|of|IN the|the|DT PmrA|pmra|NN -|-|HYPH PmrB|pmrb|NN two|two|CD -|-|HYPH com|com|NN -|-|HYPH ponent|ponent|NN system|system|NN can|can|MD be|be|VB modulated|modulate|VBN by|by|IN either|either|CC environmental|environmental|JJ signals|signal|NNS or|or|CC mutational|mutational|JJ change|change|NN in|in|IN the|the|DT pmrA|pmra|NN and|and|CC pmrB|pmrb|NN genes|gene|NNS (|(|-LRB- 20|20|CD ,|,|, 28|28|CD ,|,|, 33|33|CD ,|,|, 38|38|CD )|)|-RRB- .|.|. 
After|after|IN being|be|VBG phosphorylated|phosphorylate|VBN by|by|IN PmrB|pmrb|NN ,|,|, PmrA|pmra|NN can|can|MD effectively|effectively|RB bind|bind|VB to|to|IN the|the|DT transcriptional|transcriptional|JJ sites|site|NNS of|of|IN other|other|JJ genes|gene|NNS (|(|-LRB- pmrE|pmre|NN ,|,|, pmrHFIJKLM|pmrhfijklm|NN ,|,|, and|and|CC pmrC|pmrc|NN )|)|-RRB- and|and|CC activate|activate|VB their|they|PRP$ transcription|transcription|NN .|.|. 
As|as|IN shown|show|VBN for|for|IN both|both|DT S.|S.|NNP Typhimurium|Typhimurium|NNP and|and|CC P.|P.|NNP aeruginosa|aeruginosa|NNP ,|,|, the|the|DT proteins|proteins|NN encoded|encode|VBN by|by|IN these|these|DT genes|gene|NNS modify|modify|VBP the|the|DT LPS|lps|NN core|core|NN and|and|CC lipid|lipid|NN A|a|NN regions|region|NNS with|with|IN ethanolamine|ethanolamine|NN and|and|CC add|add|VB aminoarabinose|aminoarabinose|NN to|to|IN lipid|lipid|NN A|a|NN (|(|-LRB- 7|7|CD ,|,|, 8|8|CD ,|,|, 16|16|CD ,|,|, 20|20|CD )|)|-RRB- .|.|. 
These|these|DT modiﬁcations|modiﬁcations|NNS make|make|VBP the|the|DT LPS|lps|NN less|less|RBR negatively|negatively|RB charged|charge|VBN and|and|CC thereby|thereby|RB decrease|decrease|VB the|the|DT binding|binding|NN of|of|IN colistin|colistin|NN .|.|. 
This|this|DT work|work|NN is|be|VBZ focused|focus|VBN on|on|IN the|the|DT mutational|mutational|JJ study|study|NN of|of|IN the|the|DT development|development|NN of|of|IN colistin|colistin|NN resistance|resistance|NN .|.|. 
To|to|IN our|we|PRP$ knowledge|knowledge|NN ,|,|, until|until|IN now|now|RB only|only|RB one|one|CD missense|missense|NN mutation|mutation|NN (|(|-LRB- R81H|r81h|NN )|)|-RRB- in|in|IN the|the|DT pmrA|pmra|NN gene|gene|NN in|in|IN S.|S.|NNP Typhimurium|Typhimurium|NNP and|and|CC two|two|CD missense|missense|NN mutations|mutation|NNS (|(|-LRB- L243Q|l243q|NN and|and|CC A248V|a248v|NN )|)|-RRB- in|in|IN the|the|DT pmrB|pmrb|NN gene|gene|NN in|in|IN P.|P.|NNP aeruginosa|aeruginosa|NNP have|have|VBP been|be|VBN identiﬁed|identiﬁed|VBN (|(|-LRB- 20|20|CD ,|,|, 28|28|CD )|)|-RRB- .|.|. 
Although|although|IN it|it|PRP was|be|VBD suggested|suggest|VBN that|that|IN PM|pm|NN resistance|resistance|NN could|could|MD result|result|VB from|from|IN mutations|mutation|NNS in|in|IN the|the|DT pmrB|pmrb|NN gene|gene|NN that|that|WDT lead|lead|VBP to|to|IN a|a|DT hyperactive|hyperactive|JJ kinase|kinase|NN or|or|CC decreased|decrease|VBD phosphatase|phosphatase|NN activity|activity|NN ,|,|, few|few|JJ mutations|mutation|NNS have|have|VBP been|be|VBN identiﬁed|identiﬁed|VBN ,|,|, and|and|CC how|how|WRB these|these|DT mutations|mutation|NNS affect|affect|VBP the|the|DT PmrA|pmra|NN -|-|HYPH PmrB|pmrb|NN two|two|CD -|-|HYPH component|component|NN regulatory|regulatory|JJ system|system|NN is|be|VBZ still|still|RB unclear|unclear|JJ (|(|-LRB- 20|20|CD ,|,|, 28|28|CD )|)|-RRB- .|.|. 
229|229|CD Antibiotic|antibiotic|JJ resistance|resistance|NN typically|typically|RB causes|cause|VBZ perturbations|perturbation|NNS in|in|IN the|the|DT activities|activity|NNS of|of|IN cellular|cellular|JJ processes|process|NNS that|that|WDT often|often|RB have|have|VBP deleterious|deleterious|JJ effects|effect|NNS on|on|IN cellular|cellular|JJ ﬁtness|ﬁtness|NN ,|,|, quantiﬁable|quantiﬁable|NN as|as|IN changes|change|NNS in|in|IN ﬁtness|ﬁtness|NN parameters|parameter|NNS ,|,|, such|such|JJ as|as|IN virulence|virulence|NN ,|,|, growth|growth|NN rates|rate|NNS ,|,|, and|and|CC transmission|transmission|NN rates|rate|NNS (|(|-LRB- 2|2|CD )|)|-RRB- .|.|. 
Both|both|DT experimental|experimental|JJ and|and|CC theoretical|theoretical|JJ data|datum|NNS suggest|suggest|VBP that|that|IN the|the|DT biological|biological|JJ ﬁtness|ﬁtness|NN cost|cost|NN of|of|IN resistance|resistance|NN is|be|VBZ a|a|DT major|major|JJ determinant|determinant|NN of|of|IN the|the|DT rate|rate|NN of|of|IN resistance|resistance|NN development|development|NN ,|,|, and|and|CC knowledge|knowledge|NN of|of|IN the|the|DT ﬁtness|ﬁtness|NN costs|cost|NNS is|be|VBZ thus|thus|RB important|important|JJ if|if|IN we|we|PRP want|want|VBP to|to|TO be|be|VB able|able|JJ to|to|TO predict|predict|VB resistance|resistance|NN development|development|NN in|in|IN different|different|JJ clinical|clinical|JJ settings|setting|NNS ,|,|, as|as|RB well|well|RB as|as|IN to|to|TO evaluate|evaluate|VB the|the|DT effects|effect|NNS of|of|IN interventions|intervention|NNS to|to|TO reduce|reduce|VB antibiotic|antibiotic|JJ resistance|resistance|NN .|.|. 
We|we|PRP isolated|isolate|VBD 44|44|CD spontaneous|spontaneous|JJ mutants|mutant|NNS of|of|IN S.|S.|NNP Typhimurium|Typhimurium|NNP LT2|LT2|NNP that|that|WDT showed|show|VBD reduced|reduce|VBN susceptibility|susceptibility|NN to|to|IN colistin|colistin|NN sulfate|sulfate|NN (|(|-LRB- referred|refer|VBN to|to|IN as|as|IN colistin|colistin|NN throughout|throughout|IN the|the|DT text|text|NN )|)|-RRB- and|and|CC carried|carry|VBN mutations|mutation|NNS in|in|IN either|either|CC the|the|DT pmrA|pmra|NN or|or|CC pmrB|pmrb|NN gene|gene|NN .|.|. 
We|we|PRP determined|determine|VBD the|the|DT mutation|mutation|NN rate|rate|NN to|to|IN colistin|colistin|NN resistance|resistance|NN and|and|CC measured|measure|VBD the|the|DT ﬁtness|ﬁtness|NN of|of|IN the|the|DT pmrAB|pmrab|NN mutants|mutant|NNS in|in|FW vitro|vitro|FW and|and|CC in|in|IN a|a|DT mouse|mouse|NN model|model|NN .|.|. 
MATERIALS|MATERIALS|NNP AND|and|CC METHODS|METHODS|NNPS Isolation|isolation|NN of|of|IN colistin|colistin|NN -|-|HYPH resistant|resistant|JJ mutants|mutant|NNS .|.|. 
For|for|IN all|all|DT experiments|experiment|NNS ,|,|, S.|S.|NNP Typhimurium|Typhimurium|NNP LT2|LT2|NNP (|(|-LRB- referred|refer|VBN to|to|IN as|as|IN S.|S.|NNP Typhimurium|Typhimurium|NNP )|)|-RRB- was|be|VBD used|use|VBN .|.|. 
One|one|CD motivation|motivation|NN for|for|IN using|use|VBG S.|S.|NNP Typhimurium|Typhimurium|NNP in|in|IN this|this|DT study|study|NN (|(|-LRB- apart|apart|RB from|from|IN the|the|DT fact|fact|NN that|that|IN it|it|PRP is|be|VBZ a|a|DT genetically|genetically|RB amenable|amenable|JJ experimental|experimental|JJ system|system|NN with|with|IN a|a|DT robust|robust|JJ and|and|CC widely|widely|RB used|use|VBN animal|animal|NN infection|infection|NN model|model|NN )|)|-RRB- is|be|VBZ the|the|DT fact|fact|NN that|that|IN many|many|JJ of|of|IN the|the|DT previous|previous|JJ studies|study|NNS of|of|IN the|the|DT PmrAB|pmrab|NN system|system|NN have|have|VBP been|be|VBN performed|perform|VBN in|in|IN this|this|DT bacterium|bacterium|NN (|(|-LRB- 8|8|CD ,|,|, 18|18|CD ,|,|, 28|28|CD )|)|-RRB- ,|,|, allowing|allow|VBG us|we|PRP to|to|TO make|make|VB proper|proper|JJ comparisons|comparison|NNS between|between|IN our|we|PRP$ study|study|NN and|and|CC previous|previous|JJ studies|study|NNS .|.|. 
From|from|IN each|each|DT of|of|IN several|several|JJ independent|independent|JJ overnight|overnight|JJ cultures|culture|NNS ,|,|, 2|2|CD 107|107|CD cells|cell|NNS were|be|VBD plated|plate|VBN on|on|IN Luria|Luria|NNP agar|agar|NN (|(|-LRB- LA|LA|NNP )|)|-RRB- plates|plate|NNS supplemented|supplement|VBN with|with|IN 1.25|1.25|CD mg|mg|NN /|/|SYM liter|liter|NN (|(|-LRB- 10|10|CD times|time|NNS the|the|DT MIC|mic|NN of|of|IN colistin|colistin|NN for|for|IN the|the|DT susceptible|susceptible|JJ strain|strain|NN )|)|-RRB- or|or|CC 6.25|6.25|CD mg|mg|NN /|/|SYM liter|liter|NN (|(|-LRB- 50|50|CD times|time|NNS the|the|DT MIC|mic|NN of|of|IN colistin|colistin|NN for|for|IN the|the|DT susceptible|susceptible|JJ strain|strain|NN )|)|-RRB- colistin|colistin|NN .|.|. 
Fortyfour|Fortyfour|NNP independent|independent|JJ mutants|mutant|NNS with|with|IN reduced|reduce|VBN susceptibility|susceptibility|NN to|to|IN colistin|colistin|NN ,|,|, 27|27|CD from|from|IN plates|plate|NNS containing|contain|VBG 6.25|6.25|CD mg|mg|NN /|/|SYM liter|liter|NN colistin|colistin|NN and|and|CC 17|17|CD from|from|IN plates|plate|NNS containing|contain|VBG 1.25|1.25|CD mg|mg|NN /|/|SYM liter|liter|NN colistin|colistin|NN ,|,|, were|be|VBD isolated|isolate|VBN ,|,|, restreaked|restreak|VBN on|on|IN LA|LA|NNP -|-|HYPH colistin|colistin|NN plates|plate|NNS ,|,|, and|and|CC then|then|RB stored|store|VBN at|at|IN 80|80|CD °C|°c|NN .|.|. 
Determination|determination|NN of|of|IN the|the|DT in|in|FW vitro|vitro|FW mutation|mutation|NN rate|rate|NN .|.|. 
Approximately|approximately|RB 108|108|CD CFU|CFU|NNP from|from|IN each|each|DT of|of|IN 25|25|CD independent|independent|JJ cultures|culture|NNS were|be|VBD inoculated|inoculate|VBN onto|onto|IN LA|LA|NNP plates|plate|NNS containing|contain|VBG 1.25|1.25|CD mg|mg|NN /|/|SYM liter|liter|NN colistin|colistin|NN ,|,|, and|and|CC the|the|DT number|number|NN of|of|IN colonies|colony|NNS with|with|IN reduced|reduce|VBN susceptibility|susceptibility|NN to|to|IN colis|colis|NN -|-|HYPH tin|tin|NN was|be|VBD scored|score|VBN the|the|DT next|next|JJ day|day|NN .|.|. 
The|the|DT mutation|mutation|NN rate|rate|NN was|be|VBD calculated|calculate|VBN as|as|IN the|the|DT median|median|JJ number|number|NN of|of|IN colonies|colony|NNS with|with|IN reduced|reduce|VBN susceptibility|susceptibility|NN divided|divide|VBN by|by|IN the|the|DT total|total|JJ number|number|NN of|of|IN plated|plate|VBN cells|cell|NNS as|as|IN described|describe|VBN previously|previously|RB (|(|-LRB- 15|15|CD )|)|-RRB- .|.|. 
Determination|determination|NN of|of|IN MIC|MIC|NNP and|and|CC cross-resistance|cross-resistance|NN .|.|. 
The|the|DT MICs|mic|NNS of|of|IN colistin|colistin|NN for|for|IN the|the|DT mutants|mutant|NNS were|be|VBD determined|determine|VBN using|use|VBG Etest|Etest|NNP strips|strip|NNS from|from|IN AB|AB|NNP Biodisk|Biodisk|NNP as|as|IN described|describe|VBN by|by|IN the|the|DT manufacturer|manufacturer|NN .|.|. 
Each|each|DT MIC|mic|NN was|be|VBD determined|determine|VBN in|in|IN at|at|IN least|least|RBS three|three|CD separate|separate|JJ experiments|experiment|NNS .|.|. 
Cross-resistance|cross-resistance|NN to|to|TO ﬁve|ﬁve|VB antimicrobial|antimicrobial|JJ peptides|peptide|NNS (|(|-LRB- AMPs|amp|NNS )|)|-RRB- ,|,|, CNY100|cny100|NN ,|,|, LL|ll|NN -|-|HYPH 37|37|CD ,|,|, PR|pr|NN -|-|HYPH 39|39|CD ,|,|, protamine|protamine|NN ,|,|, and|and|CC bleomycin|bleomycin|NN ,|,|, was|be|VBD determined|determine|VBN in|in|IN 96|96|CD -|-|HYPH microwell|microwell|NN plates|plate|NNS (|(|-LRB- round|round|JJ bottom|bottom|NN ;|;|: Nunc|Nunc|NNP A|A|NNP /|/|HYPH S|S|NNP ,|,|, Roskilde|Roskilde|NNP ,|,|, Denmark|Denmark|NNP )|)|-RRB- .|.|. 
The|the|DT susceptible|susceptible|JJ wild|wild|JJ type|type|NN (|(|-LRB- DA6192|da6192|NN )|)|-RRB- ,|,|, two|two|CD pmrA|pmra|NN mutants|mutant|NNS (|(|-LRB- DA10826|da10826|NN and|and|CC DA10840|da10840|NN )|)|-RRB- ,|,|, and|and|CC two|two|CD pmrB|pmrb|NN mutants|mutant|NNS (|(|-LRB- DA10833|da10833|NN and|and|CC DA10845|da10845|NN )|)|-RRB- were|be|VBD grown|grow|VBN to|to|IN mid-exponential|mid-exponential|JJ phase|phase|NN and|and|CC diluted|dilute|VBN to|to|IN approximately|approximately|RB 105|105|CD CFU|CFU|NNP /|/|SYM ml|ml|NN ,|,|, and|and|CC then|then|RB 90|90|CD l|l|NN of|of|IN the|the|DT diluted|dilute|VBN bacteria|bacterium|NNS was|be|VBD mixed|mix|VBN with|with|IN various|various|JJ amounts|amount|NNS of|of|IN AMPs|amp|NNS to|to|IN a|a|DT ﬁnal|ﬁnal|JJ volume|volume|NN of|of|IN 100|100|CD l|l|NN .|.|. 
The|the|DT plates|plate|NNS were|be|VBD incubated|incubate|VBN at|at|IN 37|37|CD °C|°c|NN with|with|IN shaking|shake|VBG at|at|IN 200|200|CD rpm|rpm|NN overnight|overnight|RB .|.|. 
The|the|DT MIC|MIC|NNP was|be|VBD deﬁned|deﬁned|VBN as|as|IN the|the|DT lowest|lowest|JJS concentration|concentration|NN of|of|IN AMPs|amp|NNS giving|give|VBG no|no|DT visible|visible|JJ growth|growth|NN .|.|. 
Time|time|NN -|-|HYPH kill|kill|NN assay|assay|NN .|.|. 
Two|two|CD pmrA|pmra|NN (|(|-LRB- DA10826|da10826|NN and|and|CC D10840|d10840|NN )|)|-RRB- and|and|CC two|two|CD pmrB|pmrb|NN (|(|-LRB- DA10829|da10829|NN and|and|CC DA10845|da10845|NN )|)|-RRB- spontaneous|spontaneous|JJ mutants|mutant|NNS and|and|CC the|the|DT wild|wild|JJ -|-|HYPH type|type|NN strain|strain|NN (|(|-LRB- DA6192|da6192|NN )|)|-RRB- were|be|VBD used|use|VBN to|to|TO examine|examine|VB the|the|DT killing|kill|VBG kinetics|kinetics|NN of|of|IN colistin|colistin|NN .|.|. 
About|about|RB 106|106|CD cells|cell|NNS in|in|IN mid-exponential|mid-exponential|JJ phase|phase|NN (|(|-LRB- optical|optical|JJ density|density|NN [|[|-LRB- OD|od|NN ]|]|-RRB- 0.5|0.5|CD )|)|-RRB- were|be|VBD inoculated|inoculate|VBN into|into|IN 10|10|CD ml|ml|NN of|of|IN LB|LB|NNP broth|broth|NN in|in|IN a|a|DT ﬂask|ﬂask|NN supplemented|supplement|VBN with|with|IN 0|0|CD ,|,|, 0.25|0.25|CD ,|,|, 1|1|CD ,|,|, 4|4|CD ,|,|, or|or|CC 16|16|CD mg|mg|NN /|/|SYM liter|liter|NN colistin|colistin|NN .|.|. 
The|the|DT ﬂasks|ﬂasks|NNS were|be|VBD shaken|shake|VBN at|at|IN 200|200|CD rpm|rpm|NN at|at|IN 37|37|CD °C|°c|NN .|.|. 
Samples|sample|NNS were|be|VBD taken|take|VBN at|at|IN ﬁve|ﬁve|NN time|time|NN points|point|NNS ,|,|, zero|zero|CD (|(|-LRB- prior|prior|JJ to|to|IN the|the|DT addition|addition|NN of|of|IN antibiotic|antibiotic|JJ )|)|-RRB- ,|,|, 10|10|CD min|min|NN ,|,|, 30|30|CD min|min|NN ,|,|, 240|240|CD min|min|NN ,|,|, and|and|CC 480|480|CD min|min|NN ,|,|, and|and|CC viable|viable|JJ counts|count|NNS were|be|VBD determined|determine|VBN for|for|IN each|each|DT time|time|NN point|point|NN .|.|. 
PCR|pcr|NN and|and|CC sequencing|sequencing|NN .|.|. 
The|the|DT primers|primer|NNS for|for|IN the|the|DT relevant|relevant|JJ genes|gene|NNS were|be|VBD designed|design|VBN using|use|VBG NetPrimer|NetPrimer|NNP .|.|. 
For|for|IN DNA|dna|NN sequencing|sequencing|NN ,|,|, the|the|DT gene|gene|NN of|of|IN interest|interest|NN was|be|VBD PCR|pcr|NN ampliﬁed|ampliﬁed|VBN and|and|CC puriﬁed|puriﬁed|VBN from|from|IN solution|solution|NN using|use|VBG GFX|GFX|NNP PCR|pcr|NN DNA|dna|NN and|and|CC a|a|DT gel|gel|NN band|band|NN puriﬁcation|puriﬁcation|NN kit|kit|NN (|(|-LRB- GE|GE|NNP Healthcare|Healthcare|NNP )|)|-RRB- .|.|. 
The|the|DT puriﬁed|puriﬁed|JJ PCR|pcr|NN product|product|NN was|be|VBD mixed|mix|VBN with|with|IN the|the|DT sequencing|sequencing|NN primers|primer|NNS ,|,|, and|and|CC the|the|DT samples|sample|NNS were|be|VBD dried|dry|VBN in|in|IN a|a|DT vacuum|vacuum|NN and|and|CC sent|send|VBN to|to|IN the|the|DT MWG|MWG|NNP Biotech|Biotech|NNP Company|Company|NNP ,|,|, Germany|Germany|NNP ,|,|, for|for|IN DNA|dna|NN sequencing|sequencing|NN .|.|. 
The|the|DT sequences|sequence|NNS were|be|VBD analyzed|analyze|VBN using|use|VBG Mega|mega|JJ 3.1|3.1|CD .|.|. 
The|the|DT primers|primer|NNS used|use|VBN for|for|IN ampliﬁcation|ampliﬁcation|NN and|and|CC sequencing|sequencing|NN were|be|VBD as|as|IN follows|follow|VBZ :|:|: S.|S.|NNP Typhimurium|Typhimurium|NNP LT2|LT2|NNP pmrA|pmrA|NNP ,|,|, Fwd|Fwd|NNP (|(|-LRB- 5|5|CD -|-|SYM CGC|cgc|NN GAA|gaa|NN TTT|ttt|NN CGT|cgt|NN GCA|gca|NN TGA|tga|NN TAT|tat|NN G|g|NN -|-|HYPH 3|3|CD )|)|-RRB- and|and|CC Rev|rev|NN (|(|-LRB- 5|5|CD -|-|SYM ATG|atg|NN TCC|tcc|NN CGA|cga|NN TGC|tgc|NN TCA|tca|NN TTT|ttt|NN GGC|ggc|NN -|-|HYPH 3|3|CD )|)|-RRB- ,|,|, and|and|CC pmrB|pmrb|NN ,|,|, Fwd|Fwd|NNP (|(|-LRB- 5|5|CD AGG|agg|NN AAA|aaa|NN TTC|ttc|NN TGG|tgg|NN GCG|gcg|NN AGC|agc|NN A-3|a-3|NN )|)|-RRB- and|and|CC Rev|rev|NN (|(|-LRB- 5|5|CD -|-|SYM CGT|cgt|NN TTT|ttt|NN CAG|cag|NN CGA|cga|NN AGA|aga|NN GCG|gcg|NN A-3|a-3|NN )|)|-RRB- .|.|. 
Measurements|measurement|NNS of|of|IN growth|growth|NN rates|rate|NNS and|and|CC starvation|starvation|NN survival|survival|NN .|.|. 
Exponential|exponential|JJ growth|growth|NN rates|rate|NNS were|be|VBD measured|measure|VBN in|in|IN LB|LB|NNP broth|broth|NN and|and|CC M9|m9|NN -|-|HYPH glycerol|glycerol|NN (|(|-LRB- 0.2|0.2|CD %|%|NN )|)|-RRB- minimum|minimum|JJ medium|medium|NN at|at|IN 37|37|CD °C|°c|NN .|.|. 
In|in|IN a|a|DT Bioscreen|Bioscreen|NNP plate|plate|NN ,|,|, approximately|approximately|RB 104|104|CD and|and|CC 108|108|CD cells|cell|NNS were|be|VBD inoculated|inoculate|VBN into|into|IN 400|400|CD l|l|NN LB|LB|NNP medium|medium|NN and|and|CC M9|m9|NN -|-|HYPH glycerol|glycerol|NN medium|medium|NN ,|,|, respectively|respectively|RB ,|,|, and|and|CC the|the|DT absorbance|absorbance|NN at|at|IN 600|600|CD nm|nm|NN was|be|VBD read|read|VBN every|every|DT 4|4|CD min|min|NN using|use|VBG a|a|DT BioscreenC|bioscreenc|NN reader|reader|NN .|.|. 
Growth|growth|NN rates|rate|NNS were|be|VBD calculated|calculate|VBN based|base|VBN on|on|IN OD|od|NN values|value|NNS at|at|IN 600|600|CD nm|nm|NNS measured|measure|VBN between|between|IN 0.08|0.08|CD and|and|CC 0.15|0.15|CD in|in|IN the|the|DT exponential|exponential|JJ phase|phase|NN .|.|. 
Relative|relative|JJ growth|growth|NN rates|rate|NNS were|be|VBD calculated|calculate|VBN as|as|IN the|the|DT growth|growth|NN rates|rate|NNS of|of|IN the|the|DT mutants|mutant|NNS divided|divide|VBN by|by|IN the|the|DT growth|growth|NN rate|rate|NN of|of|IN the|the|DT susceptible|susceptible|JJ wild|wild|JJ -|-|HYPH type|type|NN strain|strain|NN (|(|-LRB- DA6192|da6192|NN )|)|-RRB- from|from|IN the|the|DT same|same|JJ experiment|experiment|NN .|.|. 
Standard|standard|JJ errors|error|NNS were|be|VBD 2|2|CD %|%|NN of|of|IN the|the|DT average|average|NN ,|,|, and|and|CC differences|difference|NNS greater|greater|JJR than|than|IN 2|2|CD %|%|NN were|be|VBD considered|consider|VBN signiﬁcant|signiﬁcant|NN .|.|. 
The|the|DT starvation|starvation|NN survival|survival|NN of|of|IN the|the|DT mutants|mutant|NNS was|be|VBD determined|determine|VBN by|by|IN incubating|incubate|VBG four|four|CD independent|independent|JJ lineages|lineage|NNS (|(|-LRB- each|each|DT )|)|-RRB- of|of|IN the|the|DT strains|strain|NNS DA6192|da6192|NN (|(|-LRB- wild|wild|JJ type|type|NN )|)|-RRB- ,|,|, DA10826|da10826|NN ,|,|, DA10840|da10840|NN ,|,|, DA10833|da10833|NN ,|,|, and|and|CC DA10853|da10853|NN in|in|IN LB|LB|NNP over|over|IN an|a|DT extended|extended|JJ period|period|NN without|without|IN changing|change|VBG the|the|DT medium|medium|NN .|.|. 
Each|each|DT independent|independent|JJ lineage|lineage|NN was|be|VBD initiated|initiate|VBN by|by|IN inoculating|inoculate|VBG 1.5|1.5|CD ml|ml|NN LB|LB|NNP with|with|IN 105|105|CD bacterial|bacterial|JJ cells|cell|NNS .|.|. 
The|the|DT tubes|tube|NNS were|be|VBD incubated|incubate|VBN at|at|IN 37|37|CD °C|°c|NN for|for|IN 21|21|CD days|day|NNS ,|,|, and|and|CC samples|sample|NNS were|be|VBD plated|plate|VBN on|on|IN LA|LA|NNP plates|plate|NNS at|at|IN regular|regular|JJ intervals|interval|NNS .|.|. 
The|the|DT survival|survival|NN percentage|percentage|NN compared|compare|VBN to|to|IN the|the|DT number|number|NN of|of|IN CFU|CFU|NNP after|after|IN an|a|DT overnight|overnight|JJ incubation|incubation|NN was|be|VBD calculated|calculate|VBN for|for|IN each|each|DT sampling|sampling|NN time|time|NN point|point|NN .|.|. 
Standard|standard|JJ errors|error|NNS were|be|VBD 50|50|CD %|%|NN of|of|IN the|the|DT average|average|JJ values|value|NNS ,|,|, and|and|CC the|the|DT small|small|JJ differences|difference|NNS in|in|IN survival|survival|NN (|(|-LRB- see|see|VB Fig.|fig.|NN 3|3|CD )|)|-RRB- were|be|VBD not|not|RB signiﬁcant|signiﬁcant|JJ .|.|. 
Animal|animal|NN experiments|experiment|NNS .|.|. 
The|the|DT in|in|FW vivo|vivo|FW ﬁtness|ﬁtness|NN of|of|IN two|two|CD pmrA|pmra|NN (|(|-LRB- DA10826|da10826|NN and|and|CC D10840|d10840|NN )|)|-RRB- and|and|CC two|two|CD pmrB|pmrb|NN (|(|-LRB- DA10833|da10833|NN and|and|CC DA10853|da10853|NN )|)|-RRB- mutants|mutant|NNS was|be|VBD measured|measure|VBN by|by|IN performing|perform|VBG competition|competition|NN experiments|experiment|NNS in|in|IN mice|mouse|NNS .|.|. 
These|these|DT experiments|experiment|NNS were|be|VBD carried|carry|VBN out|out|RP at|at|IN the|the|DT animal|animal|NN facility|facility|NN at|at|IN the|the|DT Microbiology|Microbiology|NNP and|and|CC Tumor|Tumor|NNP Biology|Biology|NNP Centre|Centre|NNP ,|,|, Karolinska|Karolinska|NNP Institute|Institute|NNP (|(|-LRB- Stockholm|Stockholm|NNP ,|,|, Sweden|Sweden|NNP )|)|-RRB- ,|,|, in|in|IN compliance|compliance|NN with|with|IN national|national|JJ and|and|CC institutional|institutional|JJ guidelines|guideline|NNS (|(|-LRB- ethical|ethical|JJ permit|permit|NN N107|n107|NN /|/|HYPH 06|06|NN )|)|-RRB- .|.|. 
Each|each|DT bacterial|bacterial|JJ strain|strain|NN was|be|VBD grown|grow|VBN to|to|IN logarithmic|logarithmic|JJ growth|growth|NN phase|phase|NN ,|,|, diluted|dilute|VBN ,|,|, and|and|CC mixed|mix|VBN with|with|IN strain|strain|NN DA6080|da6080|NN (|(|-LRB- a|a|DT genetically|genetically|RB tagged|tag|VBN reference|reference|NN competitor|competitor|NN that|that|WDT carries|carry|VBZ a|a|DT selectively|selectively|RB neutral|neutral|JJ MudJ|mudj|NN element|element|NN with|with|IN a|a|DT kanamycin|kanamycin|NN resistance|resistance|NN gene|gene|NN inserted|insert|VBN in|in|IN the|the|DT cob|cob|NN operon|operon|NN [|[|-LRB- 22|22|CD ]|]|-RRB- )|)|-RRB- at|at|IN an|a|DT approximately|approximately|RB 1:1|1:1|CD ratio|ratio|NN in|in|IN phosphate|phosphate|NN -|-|HYPH buffered|buffer|VBN saline|saline|NN (|(|-LRB- PBS|pbs|NN )|)|-RRB- .|.|. 
For|for|IN each|each|DT competition|competition|NN experiment|experiment|NN ,|,|, ﬁve|ﬁve|NN 7|7|CD -|-|HYPH week|week|NN -|-|HYPH old|old|JJ female|female|JJ BALB|balb|NN /|/|HYPH c|c|NN mice|mouse|NNS were|be|VBD infected|infect|VBN with|with|IN 2|2|CD 105|105|CD cells|cell|NNS in|in|IN a|a|DT 100|100|CD -|-|HYPH l|l|NN volume|volume|NN of|of|IN PBS|pbs|NN by|by|IN intraperitoneal|intraperitoneal|JJ injection|injection|NN .|.|. 
The|the|DT mice|mouse|NNS were|be|VBD sacriﬁced|sacriﬁced|VBN after|after|IN 3|3|CD days|day|NNS ,|,|, and|and|CC the|the|DT livers|liver|NNS and|and|CC spleens|spleen|NNS were|be|VBD removed|remove|VBN and|and|CC homogenized|homogenize|VBN in|in|IN PBS|pbs|NN .|.|. 
The|the|DT ratio|ratio|NN of|of|IN mutants|mutant|NNS versus|versus|IN the|the|DT wild|wild|JJ -|-|HYPH type|type|NN reference|reference|NN strain|strain|NN was|be|VBD determined|determine|VBN by|by|IN plating|plate|VBG different|different|JJ dilutions|dilution|NNS of|of|IN the|the|DT homogenates|homogenate|NNS on|on|IN LA|LA|NNP plates|plate|NNS and|and|CC LA|LA|NNP plates|plate|NNS supplemented|supplement|VBN with|with|IN kanamycin|kanamycin|NN .|.|. 
The|the|DT competition|competition|NN index|index|NN (|(|-LRB- CI|ci|NN )|)|-RRB- was|be|VBD calculated|calculate|VBN as|as|IN the|the|DT ratio|ratio|NN between|between|IN the|the|DT mutant|mutant|NN and|and|CC wild|wild|JJ -|-|HYPH type|type|NN populations|population|NNS after|after|IN one|one|CD cycle|cycle|NN of|of|IN growth|growth|NN in|in|IN mice|mouse|NNS (|(|-LRB- 10|10|CD generations|generation|NNS )|)|-RRB- .|.|. 
From|from|IN this|this|DT value|value|NN and|and|CC the|the|DT number|number|NN of|of|IN generations|generation|NNS of|of|IN growth|growth|NN in|in|IN mice|mouse|NNS ,|,|, the|the|DT selection|selection|NN coefﬁcient|coefﬁcient|NN (|(|-LRB- s|s|AFX )|)|-RRB- was|be|VBD calculated|calculate|VBN as|as|IN follows|follow|VBZ :|:|: s|s|POS ln|ln|NN (|(|-LRB- CI|ci|NN )|)|-RRB- /|/|SYM 10|10|CD ln|ln|NN (|(|-LRB- 2|2|CD )|)|-RRB- (|(|-LRB- 22|22|CD )|)|-RRB- .|.|. 
Because|because|IN of|of|IN variation|variation|NN between|between|IN mice|mouse|NNS ,|,|, only|only|RB differences|difference|NNS in|in|IN the|the|DT CI|ci|NN greater|greater|JJR than|than|IN two|two|CD -|-|HYPH to|to|IN threefold|threefold|RB were|be|VBD considered|consider|VBN signiﬁcant|signiﬁcant|NN .|.|. 
Isolation|isolation|NN of|of|IN total|total|JJ RNA|rna|NN .|.|. 
Total|total|JJ RNA|rna|NN was|be|VBD isolated|isolate|VBN using|use|VBG the|the|DT SV|SV|NNP Total|Total|NNP RNA|rna|NN Isolation|isolation|NN System|system|NN (|(|-LRB- part|part|NN no|no|DT .|.|. 
TM048|tm048|NN )|)|-RRB- from|from|IN Promega|Promega|NNP .|.|. 
Bacterial|bacterial|JJ cell|cell|NN lysis|lysis|NN was|be|VBD done|do|VBN as|as|IN follows|follow|VBZ .|.|. 
A|a|DT culture|culture|NN was|be|VBD grown|grow|VBN overnight|overnight|RB in|in|IN LB|LB|NNP broth|broth|NN at|at|IN 37|37|CD °C|°c|NN ,|,|, and|and|CC the|the|DT following|follow|VBG day|day|NN ,|,|, the|the|DT culture|culture|NN was|be|VBD diluted|dilute|VBN 1:100|1:100|CD and|and|CC grown|grow|VBN at|at|IN 37|37|CD °C|°c|NN until|until|IN the|the|DT OD|od|NN values|value|NNS at|at|IN 600|600|CD nm|nm|NNS were|be|VBD around|around|RB 0.4|0.4|CD to|to|IN 0.5|0.5|CD .|.|. 
A|a|DT pellet|pellet|NN was|be|VBD collected|collect|VBN by|by|IN centrifuging|centrifuge|VBG 1.4|1.4|CD ml|ml|NN culture|culture|NN at|at|IN 13,200|13,200|CD rpm|rpm|NN and|and|CC was|be|VBD then|then|RB resuspended|resuspend|VBN in|in|IN 100|100|CD l|l|NN of|of|IN freshly|freshly|RB prepared|prepare|VBN Tris|tris|NN -|-|HYPH EDTA|edta|NN containing|contain|VBG 0.5|0.5|CD g|g|NN /|/|SYM liter|liter|NN lysozyme|lysozyme|NN .|.|. 
The|the|DT subsequent|subsequent|JJ steps|step|NNS were|be|VBD as|as|IN described|describe|VBN in|in|IN the|the|DT user|user|NN manual|manual|NN .|.|. 
First|first|RB -|-|HYPH strand|strand|NN synthesis|synthesis|NN of|of|IN cDNA|cdna|NN from|from|IN mRNA|mrna|NN .|.|. 
mRNA|mrna|NN was|be|VBD converted|convert|VBN to|to|IN cDNA|cdna|NN using|use|VBG the|the|DT cDNA|cdna|NN reverse|reverse|JJ transcription|transcription|NN kit|kit|NN from|from|IN Applied|Applied|NNP Biosystems|Biosystems|NNP .|.|. 
Reverse|reverse|JJ transcription|transcription|NN -|-|HYPH PCRs|pcr|NNS were|be|VBD performed|perform|VBN by|by|IN mixing|mix|VBG 10|10|CD l|l|NN isolated|isolate|VBN total|total|JJ RNA|rna|NN with|with|IN 10|10|CD l|l|NN 2|2|CD reverse|reverse|JJ transcription|transcription|NN master|master|NN mix|mix|NN .|.|. 
The|the|DT protocol|protocol|NN for|for|IN preparing|prepare|VBG 2|2|CD reverse|reverse|JJ transcription|transcription|NN master|master|NN mix|mix|NN and|and|CC the|the|DT thermal|thermal|JJ -|-|HYPH cycling|cycling|NN program|program|NN were|be|VBD according|accord|VBG to|to|IN the|the|DT manufacturer|manufacturer|NN 's|'s|POS suggestions|suggestion|NNS .|.|. 
Quantitative|quantitative|JJ real|real|JJ -|-|HYPH time|time|NN PCR|pcr|NN .|.|. 
The|the|DT quantitative|quantitative|JJ real|real|JJ -|-|HYPH time|time|NN PCR|pcr|NN technique|technique|NN based|base|VBN on|on|IN the|the|DT high|high|JJ afﬁnity|afﬁnity|NN of|of|IN SYBR|SYBR|NNP Green|Green|NNP dye|dye|VB for|for|IN double|double|JJ -|-|HYPH stranded|strand|VBN DNA|dna|NN was|be|VBD used|use|VBN .|.|. 
The|the|DT ﬂuorescence|ﬂuorescence|NN signal|signal|NN was|be|VBD monitored|monitor|VBN on|on|IN line|line|NN using|use|VBG a|a|DT MiniOpticon|MiniOpticon|NNP real|real|JJ -|-|HYPH time|time|NN PCR|pcr|NN system|system|NN (|(|-LRB- Bio-Rad|Bio-Rad|NNP Laboratories|Laboratories|NNP )|)|-RRB- .|.|. 
The|the|DT PCR|pcr|NN ampliﬁcation|ampliﬁcation|NN was|be|VBD performed|perform|VBN by|by|IN mixing|mix|VBG 12.5|12.5|CD l|l|NN cDNA|cdna|NN and|and|CC primers|primer|NNS with|with|IN 12.5|12.5|CD l|l|NN SYBR|SYBR|NNP Green|Green|NNP SuperMix|SuperMix|NNP (|(|-LRB- Bio-Rad|Bio-Rad|NNP Laboratories|Laboratories|NNP )|)|-RRB- .|.|. 
The|the|DT primers|primer|NNS used|use|VBN for|for|IN real|real|JJ -|-|HYPH time|time|NN PCR|pcr|NN were|be|VBD as|as|IN follows|follow|VBZ :|:|: S.|S.|NNP Typhi|Typhi|NNP -|-|HYPH murium|murium|NNP LT2|LT2|NNP pmrH|pmrH|NNP real|real|JJ time|time|NN ,|,|, Fwd|Fwd|NNP (|(|-LRB- 5|5|CD -|-|SYM TGT|tgt|NN CGG|cgg|NN CTA|cta|NN ACT|act|NN GGC|ggc|NN AAT|aat|NN CA|ca|NN -|-|HYPH 3|3|CD )|)|-RRB- and|and|CC Rev|rev|NN (|(|-LRB- 5|5|CD -|-|SYM GTA|gta|NN ATG|atg|NN ACC|acc|NN TCG|tcg|NN TCG|tcg|NN CCT|cct|NN TC|tc|NN -|-|HYPH 3|3|CD )|)|-RRB- ,|,|, and|and|CC recA|recA|NNP real|real|JJ time|time|NN ,|,|, Fwd|Fwd|NNP (|(|-LRB- 5|5|CD -|-|SYM TAC|tac|NN CGA|cga|NN ACA|aca|NN TCA|tca|NN CGC|cgc|NN CAA|caa|NN TC|tc|NN -|-|HYPH 3|3|CD )|)|-RRB- and|and|CC Rev|rev|NN (|(|-LRB- 5|5|CD -|-|SYM GTA|gta|NN TGA|tga|NN TGA|tga|NN GCC|gcc|NN AGG|agg|NN CGA|cga|NN TG|tg|NN -|-|HYPH 3|3|CD )|)|-RRB- .|.|. 
Nucleotide|nucleotide|NN sequence|sequence|NN accession|accession|NN numbers|number|NNS .|.|. 
The|the|DT DNA|dna|NN sequences|sequence|NNS of|of|IN the|the|DT pmrA|pmra|NN (|(|-LRB- accession|accession|NN no|no|DT .|.|. 
NC_003197|nc_003197|NN )|)|-RRB- and|and|CC pmrB|pmrb|NN (|(|-LRB- accession|accession|NN no|no|DT .|.|. 
NC_003197|nc_003197|NN )|)|-RRB- genes|gene|NNS have|have|VBP been|be|VBN deposited|deposit|VBN in|in|IN GenBank|GenBank|NNP a|a|DT DNA|dna|NN changes|change|NNS and|and|CC amino|amino|NN acid|acid|NN substitutions|substitution|NNS (|(|-LRB- using|use|VBG the|the|DT one|one|CD -|-|HYPH letter|letter|NN code|code|NN )|)|-RRB- in|in|IN the|the|DT PmrA|pmra|NN and|and|CC PmrB|pmrb|NN proteins|proteins|NN are|be|VBP indicated|indicate|VBN .|.|. 
MIC|mic|NN Strain|strain|NN Genotypea|Genotypea|NNP Origin|Origin|NNP (|(|-LRB- mg|mg|NN /|/|SYM liter|liter|NN )|)|-RRB- Wild|wild|JJ type|type|NN (|(|-LRB- parent|parent|NN )|)|-RRB- DA6192|da6192|NN Strain|strain|NN 0.125|0.125|CD collection|collection|NN This|this|DT study|study|NN This|this|DT study|study|NN This|this|DT study|study|NN This|this|DT study|study|NN This|this|DT study|study|NN This|this|DT study|study|NN This|this|DT study|study|NN This|this|DT study|study|NN This|this|DT study|study|NN This|this|DT study|study|NN This|this|DT study|study|NN This|this|DT study|study|NN This|this|DT study|study|NN This|this|DT study|study|NN This|this|DT study|study|NN This|this|DT study|study|NN This|this|DT study|study|NN This|this|DT study|study|NN This|this|DT study|study|NN This|this|DT study|study|NN This|this|DT study|study|NN This|this|DT study|study|NN This|this|DT study|study|NN This|this|DT study|study|NN This|this|DT study|study|NN This|this|DT study|study|NN This|this|DT study|study|NN pmrA|pmra|NN (|(|-LRB- ggg3agg|ggg3agg|NN ,|,|, G15R|g15r|NN )|)|-RRB- pmrA|pmra|NN (|(|-LRB- GGG3GAG|ggg3gag|NN ,|,|, G53E|g53e|NN )|)|-RRB- pmrA|pmra|NN (|(|-LRB- GGG3AGG|ggg3agg|NN ,|,|, G53R|g53r|NN )|)|-RRB- pmrA|pmra|NN (|(|-LRB- CGC3TGC|cgc3tgc|NN ,|,|, R81C|r81c|NN )|)|-RRB- pmrA|pmra|NN (|(|-LRB- CGC3CAC|cgc3cac|NN ,|,|, R81H|r81h|NN )|)|-RRB- pmrB|pmrb|NN (|(|-LRB- TTA3TCA|tta3tca|NN ,|,|, L14S|l14s|NN )|)|-RRB- pmrB|pmrb|NN (|(|-LRB- TTTA3TTC|ttta3ttc|NN ,|,|, L14F|l14f|NN )|)|-RRB- pmrB|pmrb|NN (|(|-LRB- CTG3CCG|ctg3ccg|NN ,|,|, L22P|l22p|NN )|)|-RRB- pmrB|pmrb|NN (|(|-LRB- AGT3AGA|agt3aga|NN ,|,|, S29R|s29r|NN )|)|-RRB- pmrB|pmrb|NN (|(|-LRB- ACC3GCC|acc3gcc|NN ,|,|, T92A|t92a|NN )|)|-RRB- pmrB|pmrb|NN (|(|-LRB- CCG3CAG|ccg3cag|NN ,|,|, P94Q|p94q|NN )|)|-RRB- pmrB|pmrb|NN (|(|-LRB- GAG3GCG|gag3gcg|NN ,|,|, E121A|e121a|NN )|)|-RRB- pmrB|pmrb|NN (|(|-LRB- TCC3CCC|tcc3ccc|NN ,|,|, S124P|s124p|NN )|)|-RRB- pmrB|pmrb|NN (|(|-LRB- AAT3TAT|aat3tat|NN ,|,|, N130Y|n130y|NN )|)|-RRB- pmrB|pmrb|NN (|(|-LRB- ACC3CCC|acc3ccc|NN ,|,|, T147P|t147p|NN )|)|-RRB- pmrB|pmrb|NN (|(|-LRB- CGC3CCC|cgc3ccc|NN ,|,|, R155P|r155p|NN )|)|-RRB- pmrB|pmrb|NN (|(|-LRB- ACG3CCG|acg3ccg|NN ,|,|, T156P|t156p|NN )|)|-RRB- pmrB|pmrb|NN (|(|-LRB- ACG3ATG|acg3atg|NN ,|,|, T156|t156|NN M|m|NN )|)|-RRB- pmrB|pmrb|NN (|(|-LRB- GTG3ATG|gtg3atg|NN ,|,|, V161|v161|NN M|m|NN )|)|-RRB- pmrB|pmrb|NN (|(|-LRB- GTG3CTG|gtg3ctg|NN ,|,|, V161L|v161l|NN )|)|-RRB- pmrB|pmrb|NN (|(|-LRB- GTG3GGG|gtg3ggg|NN ,|,|, V161G|v161g|NN )|)|-RRB- pmrB|pmrb|NN (|(|-LRB- GAA3AAA|gaa3aaa|NN ,|,|, E166K|e166k|NN )|)|-RRB- pmrB|pmrb|NN (|(|-LRB- ATG3ATA|atg3ata|NN ,|,|, M186I|m186i|NN )|)|-RRB- pmrB|pmrb|NN (|(|-LRB- GGG3TGG|ggg3tgg|NN ,|,|, G206W|g206w|NN )|)|-RRB- pmrB|pmrb|NN (|(|-LRB- GGG3AGG|ggg3agg|NN ,|,|, G206R|g206r|NN )|)|-RRB- pmrB|pmrb|NN (|(|-LRB- AGC3CGC|agc3cgc|NN ,|,|, S305R|s305r|NN )|)|-RRB- pmrB|pmrb|NN (|(|-LRB- AGC3AGA|agc3aga|NN ,|,|, S305R|s305r|NN )|)|-RRB- DA10844|da10844|NN DA10826|da10826|NN DA10850|da10850|NN DA10857|da10857|NN DA10840|da10840|NN DA10865|da10865|NN DA10843|da10843|NN DA10849|da10849|NN DA10829|da10829|NN DA10832|da10832|NN DA10837|da10837|NN DA10862|da10862|NN DA10839|da10839|NN DA10853|da10853|NN DA10874|da10874|NN DA10838|da10838|NN DA10848|da10848|NN DA10854|da10854|NN DA10856|da10856|NN DA10835|da10835|NN DA10859|da10859|NN DA10833|da10833|NN DA10845|da10845|NN DA10863|da10863|NN DA10875|da10875|NN DA10831|da10831|NN DA10864|da10864|NN 2.7|2.7|CD 3|3|CD 3|3|CD 4|4|CD 3|3|CD 3.5|3.5|CD 3.5|3.5|CD 3.5|3.5|CD 0.5|0.5|CD 0.25|0.25|CD 2.5|2.5|CD 4|4|CD 2.3|2.3|CD 2|2|CD 2.5|2.5|CD 3.5|3.5|CD 4.4|4.4|CD 3.5|3.5|CD 4|4|CD 2|2|CD 3|3|CD 3|3|CD 2.8|2.8|CD 2|2|CD 2|2|CD 2.7|2.7|CD 2.7|2.7|CD RESULTS|result|NNS AND|and|CC DISCUSSION|discussion|NN Isolation|isolation|NN and|and|CC characterization|characterization|NN of|of|IN mutants|mutant|NNS with|with|IN reduced|reduce|VBN susceptibility|susceptibility|NN to|to|IN colistin|colistin|NN .|.|. 
In|in|IN this|this|DT work|work|NN ,|,|, we|we|PRP isolated|isolate|VBD 44|44|CD spontaneous|spontaneous|JJ mutants|mutant|NNS with|with|IN reduced|reduce|VBN susceptibility|susceptibility|NN to|to|IN colistin|colistin|NN .|.|. 
The|the|DT mutation|mutation|NN rate|rate|NN to|to|IN colistin|colistin|NN resistance|resistance|NN was|be|VBD calculated|calculate|VBN to|to|TO be|be|VB 0.6|0.6|CD 10|10|CD 6|6|CD per|per|IN cell|cell|NN per|per|IN generation|generation|NN by|by|IN using|use|VBG the|the|DT median|median|JJ method|method|NN of|of|IN Lea|Lea|NNP and|and|CC Coulson|Coulson|NNP (|(|-LRB- 15|15|CD )|)|-RRB- ,|,|, which|which|WDT is|be|VBZ several|several|JJ orders|order|NNS of|of|IN magnitude|magnitude|NN higher|higher|JJR than|than|IN the|the|DT mutation|mutation|NN rates|rate|NNS to|to|IN resistance|resistance|NN for|for|IN other|other|JJ antibiotics|antibiotic|NNS ,|,|, such|such|JJ as|as|IN streptomycin|streptomycin|NN ,|,|, rifampin|rifampin|NN (|(|-LRB- rifampicin|rifampicin|NN )|)|-RRB- ,|,|, and|and|CC nalidixic|nalidixic|JJ acid|acid|NN (|(|-LRB- 27|27|CD )|)|-RRB- .|.|. 
The|the|DT MICs|mic|NNS of|of|IN colistin|colistin|NN were|be|VBD determined|determine|VBN for|for|IN the|the|DT spontaneous|spontaneous|JJ mutants|mutant|NNS and|and|CC the|the|DT wild|wild|JJ -|-|HYPH type|type|NN strain|strain|NN ,|,|, and|and|CC for|for|IN most|most|JJS mutants|mutant|NNS ,|,|, the|the|DT MIC|MIC|NNP was|be|VBD increased|increase|VBN about|about|RB 20|20|CD -|-|HYPH to|to|IN 30-fold|30-fold|RB compared|compare|VBN to|to|IN the|the|DT susceptible|susceptible|JJ strain|strain|NN (|(|-LRB- Table|table|NN 1|1|CD )|)|-RRB- .|.|. 
The|the|DT susceptible|susceptible|JJ strain|strain|NN and|and|CC four|four|CD mutants|mutant|NNS with|with|IN slightly|slightly|RB different|different|JJ MICs|mic|NNS of|of|IN colistin|colistin|NN were|be|VBD selected|select|VBN to|to|TO investigate|investigate|VB the|the|DT bactericidal|bactericidal|JJ effect|effect|NN of|of|IN colistin|colistin|NN .|.|. 
The|the|DT CFU|CFU|NNP for|for|IN each|each|DT culture|culture|NN was|be|VBD determined|determine|VBN as|as|IN a|a|DT function|function|NN of|of|IN time|time|NN (|(|-LRB- Fig.|fig.|NN 1|1|CD )|)|-RRB- .|.|. 
For|for|IN the|the|DT susceptible|susceptible|JJ strain|strain|NN ,|,|, a|a|DT bactericidal|bactericidal|JJ effect|effect|NN was|be|VBD observed|observe|VBN at|at|IN the|the|DT 1|1|CD -|-|HYPH mg|mg|NN /|/|HYPH liter|liter|NN colistin|colistin|NN concentration|concentration|NN after|after|IN 30|30|CD min|min|NN ;|;|: for|for|IN the|the|DT three|three|CD less|less|JJR susceptible|susceptible|JJ mutants|mutant|NNS ,|,|, except|except|IN DA10826|da10826|NN ,|,|, a|a|DT bactericidal|bactericidal|JJ effect|effect|NN was|be|VBD observed|observe|VBN after|after|IN 30|30|CD or|or|CC 240|240|CD min|min|NN at|at|IN a|a|DT 16|16|CD -|-|HYPH mg|mg|NN /|/|HYPH liter|liter|NN colistin|colistin|NN concentration|concentration|NN ;|;|: for|for|IN the|the|DT mutant|mutant|NN DA10826|da10826|NN ,|,|, there|there|EX was|be|VBD only|only|RB a|a|DT ﬁvefold|ﬁvefold|JJ reduction|reduction|NN in|in|IN viability|viability|NN after|after|IN 480|480|CD min|min|NN at|at|IN 16|16|CD mg|mg|NN /|/|SYM liter|liter|NN colistin|colistin|NN .|.|. 
The|the|DT mutants|mutant|NNS with|with|IN high|high|JJ MICs|mic|NNS of|of|IN colistin|colistin|NN were|be|VBD more|more|RBR resistant|resistant|JJ to|to|IN its|its|PRP$ killing|kill|VBG effect|effect|NN .|.|. 
The|the|DT cross-resistances|cross-resistance|NNS of|of|IN two|two|CD pmrA|pmra|NN mutants|mutant|NNS (|(|-LRB- DA10826|da10826|NN and|and|CC DA10840|da10840|NN )|)|-RRB- and|and|CC two|two|CD pmrB|pmrb|NN mutants|mutant|NNS (|(|-LRB- DA10833|da10833|NN and|and|CC DA10845|da10845|NN )|)|-RRB- to|to|TO ﬁve|ﬁve|VB other|other|JJ AMPs|amp|NNS were|be|VBD determined|determine|VBN .|.|. 
No|no|DT cross-resistance|cross-resistance|NN to|to|IN either|either|CC CNY100|cny100|NN H|h|NN -|-|SYM L|l|NN ,|,|, PR|pr|NN -|-|HYPH 39|39|CD ,|,|, protamine|protamine|NN ,|,|, or|or|CC bleomycin|bleomycin|NN was|be|VBD observed|observe|VBN ,|,|, but|but|CC the|the|DT MICs|mic|NNS of|of|IN LL|ll|NN -|-|HYPH 37|37|CD increased|increase|VBD slightly|slightly|RB but|but|CC reproduc|reproduc|RB -|-|HYPH ibly|ibly|RB for|for|IN all|all|DT four|four|CD mutants|mutant|NNS (|(|-LRB- MIC|MIC|NNP 25|25|CD M|m|NN )|)|-RRB- compared|compare|VBN to|to|IN the|the|DT wild|wild|JJ -|-|HYPH type|type|NN strain|strain|NN (|(|-LRB- MIC|MIC|NNP 15|15|CD M|m|NN )|)|-RRB- (|(|-LRB- Table|table|NN 2|2|CD )|)|-RRB- .|.|. 
Identiﬁcation|identiﬁcation|NN of|of|IN colistin|colistin|NN resistance|resistance|NN mutations|mutation|NNS .|.|. 
DNA|dna|NN sequencing|sequencing|NN of|of|IN the|the|DT pmrA|pmra|NN (|(|-LRB- region|region|NN 4533719|4533719|CD to|to|IN 4534387|4534387|CD )|)|-RRB- and|and|CC pmrB|pmrb|NN (|(|-LRB- region|region|NN 4532639|4532639|CD to|to|IN 4533709|4533709|CD )|)|-RRB- genes|gene|NNS from|from|IN 44|44|CD spontaneous|spontaneous|JJ mutants|mutant|NNS showed|show|VBD that|that|IN 36|36|CD mutants|mutant|NNS had|have|VBD mutations|mutation|NNS in|in|IN the|the|DT pmrB|pmrb|NN gene|gene|NN ,|,|, representing|represent|VBG a|a|DT total|total|NN of|of|IN 22|22|CD different|different|JJ base|base|NN pair|pair|NN substitutions|substitution|NNS that|that|WDT resulted|result|VBD in|in|IN 22|22|CD amino|amino|NN acid|acid|NN changes|change|NNS located|locate|VBN at|at|IN 16|16|CD different|different|JJ positions|position|NNS ,|,|, and|and|CC 8|8|CD mutants|mutant|NNS had|have|VBD base|base|NN pair|pair|NN changes|change|NNS in|in|IN the|the|DT pmrA|pmra|NN gene|gene|NN that|that|WDT resulted|result|VBD in|in|IN 5|5|CD different|different|JJ amino|amino|NN acid|acid|NN substitutions|substitution|NNS located|locate|VBN at|at|IN 3|3|CD different|different|JJ positions|position|NNS (|(|-LRB- Table|table|NN 1|1|CD )|)|-RRB- .|.|. 
To|to|TO conﬁrm|conﬁrm|VB that|that|IN these|these|DT mutations|mutation|NNS were|be|VBD required|require|VBN and|and|CC sufﬁcient|sufﬁcient|NN to|to|TO confer|confer|VB colistin|colistin|NN resistance|resistance|NN ,|,|, they|they|PRP were|be|VBD transferred|transfer|VBN by|by|IN phage|phage|NN P22|p22|NN transduction|transduction|NN using|use|VBG a|a|DT linked|link|VBN kanamycin|kanamycin|NN resistance|resistance|NN marker|marker|NN (|(|-LRB- located|locate|VBN in|in|IN the|the|DT adi|adi|NN gene|gene|NN )|)|-RRB- to|to|IN a|a|DT wild|wild|JJ -|-|HYPH type|type|NN genetic|genetic|JJ background|background|NN .|.|. 
After|after|IN transfer|transfer|NN ,|,|, a|a|DT fraction|fraction|NN (|(|-LRB- representing|represent|VBG the|the|DT linkage|linkage|NN between|between|IN the|the|DT kanamycin|kanamycin|NN resistance|resistance|NN marker|marker|NN and|and|CC the|the|DT pmrAB|pmrab|NN genes|gene|NNS )|)|-RRB- of|of|IN the|the|DT transductants|transductant|NNS became|become|VBD less|less|RBR susceptible|susceptible|JJ to|to|IN colistin|colistin|NN ,|,|, conﬁrming|conﬁrming|VBG that|that|IN the|the|DT pmrAB|pmrab|NN mutations|mutation|NNS alone|alone|JJ conferred|confer|VBD the|the|DT resistance|resistance|NN (|(|-LRB- data|datum|NNS not|not|RB shown|show|VBN )|)|-RRB- .|.|. 
Among|among|IN the|the|DT 44|44|CD mutants|mutant|NNS examined|examine|VBN ,|,|, we|we|PRP found|find|VBD 27|27|CD different|different|JJ types|type|NNS of|of|IN mutations|mutation|NNS ,|,|, indicating|indicate|VBG that|that|IN we|we|PRP had|have|VBD identiﬁed|identiﬁed|VBN a|a|DT substantial|substantial|JJ fraction|fraction|NN of|of|IN all|all|PDT the|the|DT mutations|mutation|NNS that|that|WDT can|can|MD confer|confer|VB the|the|DT resistance|resistance|NN phenotype|phenotype|NN .|.|. 
From|from|IN the|the|DT multiple|multiple|JJ -|-|HYPH recovery|recovery|NN frequency|frequency|NN of|of|IN mutations|mutation|NNS ,|,|, the|the|DT total|total|JJ number|number|NN of|of|IN possible|possible|JJ mutations|mutation|NNS can|can|MD be|be|VB calculated|calculate|VBN .|.|. 
If|if|IN all|all|DT mutations|mutation|NNS occur|occur|VBP at|at|IN the|the|DT same|same|JJ rate|rate|NN ,|,|, the|the|DT distribution|distribution|NN of|of|IN the|the|DT number|number|NN of|of|IN occurrences|occurrence|NNS is|be|VBZ expected|expect|VBN to|to|TO be|be|VB Poissonian|poissonian|JJ .|.|. 
Thus|thus|RB ,|,|, if|if|IN 27|27|CD different|different|JJ mutations|mutation|NNS have|have|VBP been|be|VBN observed|observe|VBN among|among|IN 44|44|CD independently|independently|RB selected|select|VBN mutations|mutation|NNS ,|,|, the|the|DT number|number|NN of|of|IN possible|possible|JJ resistance|resistance|NN mutations|mutation|NNS (|(|-LRB- m|m|NN )|)|-RRB- can|can|MD be|be|VB estimated|estimate|VBN from|from|IN the|the|DT equation|equation|NN 27|27|CD m|m|NN (|(|-LRB- 1|1|CD e|e|NN 44|44|CD /|/|SYM m|m|NN )|)|-RRB- to|to|TO be|be|VB m|m|NN 41|41|CD if|if|IN one|one|CD assumes|assume|VBZ that|that|IN all|all|DT mutations|mutation|NNS occur|occur|VBP at|at|IN the|the|DT same|same|JJ rate|rate|NN and|and|CC that|that|IN their|they|PRP$ ﬁtness|ﬁtness|NN effects|effect|NNS are|be|VBP similar|similar|JJ .|.|. 
As|as|IN shown|show|VBN in|in|IN Fig.|fig.|NN 2|2|CD ,|,|, this|this|DT assumption|assumption|NN is|be|VBZ reasonable|reasonable|JJ ,|,|, and|and|CC the|the|DT ﬁtness|ﬁtness|NN differences|difference|NNS observed|observe|VBN will|will|MD have|have|VB a|a|DT negligible|negligible|JJ effect|effect|NN on|on|IN mutant|mutant|NN recovery|recovery|NN in|in|IN a|a|DT Luria|Luria|NNP -|-|HYPH Delbruck|Delbruck|NNP ﬂuctuation|ﬂuctuation|NN test|test|NN .|.|. 
Fitness|fitness|NN of|of|IN mutants|mutant|NNS with|with|IN reduced|reduce|VBN susceptibility|susceptibility|NN during|during|IN growth|growth|NN in|in|FW vitro|vitro|FW .|.|. 
The|the|DT growth|growth|NN rates|rate|NNS of|of|IN 5|5|CD pmrA|pmra|NN mutants|mutant|NNS and|and|CC 18|18|CD pmrB|pmrb|NN mutants|mutant|NNS were|be|VBD measured|measure|VBN in|in|IN LB|LB|NNP medium|medium|NN and|and|CC M9|m9|NN -|-|HYPH glycerol|glycerol|NN growth|growth|NN medium|medium|NN without|without|IN colistin|colistin|NN (|(|-LRB- Fig.|fig.|NN 2|2|CD )|)|-RRB- .|.|. 
In|in|IN LB|LB|NNP medium|medium|NN ,|,|, the|the|DT relative|relative|JJ growth|growth|NN rates|rate|NNS of|of|IN the|the|DT pmrB|pmrb|NN mutants|mutant|NNS (|(|-LRB- compared|compare|VBN to|to|IN that|that|DT of|of|IN the|the|DT wild|wild|JJ type|type|NN ,|,|, which|which|WDT was|be|VBD set|set|VBN to|to|IN 1.0|1.0|CD )|)|-RRB- varied|vary|VBD from|from|IN 0.93|0.93|CD to|to|IN 1.02|1.02|CD ,|,|, and|and|CC the|the|DT average|average|JJ ﬁtness|ﬁtness|NN was|be|VBD 0.98|0.98|CD ,|,|, indicating|indicate|VBG a|a|DT 2|2|CD %|%|NN average|average|JJ reduction|reduction|NN compared|compare|VBN with|with|IN the|the|DT wild|wild|JJ type|type|NN (|(|-LRB- unpaired|unpaired|JJ t|t|NN test|test|NN ;|;|: P|p|NN 0.018|0.018|CD )|)|-RRB- .|.|. 
The|the|DT relative|relative|JJ growth|growth|NN rates|rate|NNS of|of|IN the|the|DT pmrA|pmra|NN mutants|mutant|NNS varied|vary|VBD from|from|IN 0.92|0.92|CD to|to|IN 0.96|0.96|CD ,|,|, and|and|CC the|the|DT average|average|JJ ﬁtness|ﬁtness|NN was|be|VBD 0.94|0.94|CD ,|,|, indicating|indicate|VBG a|a|DT 6|6|CD %|%|NN reduction|reduction|NN compared|compare|VBN with|with|IN the|the|DT wild|wild|JJ type|type|NN (|(|-LRB- unpaired|unpaired|JJ t|t|NN test|test|NN ;|;|: P|p|NN 0.00013|0.00013|CD )|)|-RRB- .|.|. 
Compared|compare|VBN with|with|IN the|the|DT pmrB|pmrb|NN mutants|mutant|NNS ,|,|, the|the|DT average|average|JJ ﬁtness|ﬁtness|NN of|of|IN the|the|DT pmrA|pmra|NN mutants|mutant|NNS was|be|VBD reduced|reduce|VBN by|by|IN 4|4|CD %|%|NN (|(|-LRB- unpaired|unpaired|JJ t|t|NN test|test|NN ;|;|: P|p|NN 0.0001|0.0001|CD )|)|-RRB- .|.|. 
In|in|IN M9|m9|NN -|-|HYPH glycerol|glycerol|NN minimum|minimum|NN medium|medium|NN ,|,|, a|a|DT similar|similar|JJ but|but|CC more|more|RBR pronounced|pronounced|JJ pattern|pattern|NN was|be|VBD observed|observe|VBN .|.|. 
Thus|thus|RB ,|,|, the|the|DT relative|relative|JJ growth|growth|NN rates|rate|NNS of|of|IN the|the|DT pmrB|pmrb|NN mutants|mutant|NNS varied|vary|VBD from|from|IN 0.78|0.78|CD to|to|IN 1.1|1.1|CD and|and|CC the|the|DT average|average|JJ ﬁtness|ﬁtness|NN was|be|VBD 0.87|0.87|CD ,|,|, a|a|DT 13|13|CD %|%|NN reduction|reduction|NN compared|compare|VBN to|to|IN the|the|DT wild|wild|JJ type|type|NN (|(|-LRB- unpaired|unpaired|JJ t|t|NN test|test|NN ;|;|: P|p|NN 0.0004|0.0004|CD )|)|-RRB- .|.|. 
Furthermore|furthermore|RB ,|,|, the|the|DT relative|relative|JJ growth|growth|NN rates|rate|NNS of|of|IN the|the|DT pmrA|pmra|NN mutants|mutant|NNS varied|vary|VBD from|from|IN 0.78|0.78|CD to|to|IN 0.89|0.89|CD and|and|CC the|the|DT average|average|JJ ﬁtness|ﬁtness|NN was|be|VBD 0.82|0.82|CD ,|,|, a|a|DT 18|18|CD %|%|NN reduction|reduction|NN compared|compare|VBN to|to|IN the|the|DT wild|wild|JJ type|type|NN (|(|-LRB- unpaired|unpaired|JJ t|t|NN test|test|NN ;|;|: P|p|NN 0.00001|0.00001|CD )|)|-RRB- .|.|. 
In|in|IN M9|m9|NN -|-|HYPH glycerol|glycerol|NN medium|medium|NN ,|,|, the|the|DT average|average|JJ ﬁtness|ﬁtness|NN of|of|IN the|the|DT pmrA|pmra|NN mutants|mutant|NNS was|be|VBD 6|6|CD %|%|NN lower|lower|JJR than|than|IN that|that|DT for|for|IN the|the|DT pmrB|pmrb|NN mutants|mutant|NNS (|(|-LRB- unpaired|unpaired|JJ t|t|NN test|test|NN ;|;|: P|p|NN 0.07|0.07|CD )|)|-RRB- .|.|. 
The|the|DT ﬁtness|ﬁtness|NN costs|cost|NNS of|of|IN reduced|reduce|VBN susceptibility|susceptibility|NN to|to|IN colistin|colistin|NN were|be|VBD more|more|RBR signiﬁcant|signiﬁcant|JJ in|in|IN poor|poor|JJ medium|medium|NN than|than|IN in|in|IN rich|rich|JJ medium|medium|NN ,|,|, and|and|CC i|i|PRP both|both|DT rich|rich|JJ and|and|CC minimal|minimal|JJ media|media|NNS ,|,|, the|the|DT pmrA|pmra|NN mutants|mutant|NNS showed|show|VBD a|a|DT more|more|RBR severe|severe|JJ reduction|reduction|NN in|in|IN growth|growth|NN than|than|IN the|the|DT pmrB|pmrb|NN mutants|mutant|NNS .|.|. 
Since|since|IN the|the|DT growth|growth|NN rate|rate|NN in|in|IN exponential|exponential|JJ phase|phase|NN is|be|VBZ only|only|RB one|one|CD parameter|parameter|NN that|that|WDT determines|determine|VBZ overall|overall|JJ ﬁtness|ﬁtness|NN ,|,|, we|we|PRP also|also|RB assessed|assess|VBD the|the|DT potential|potential|NN of|of|IN these|these|DT mutants|mutant|NNS to|to|TO survive|survive|VB prolonged|prolonged|JJ starvation|starvation|NN .|.|. 
Four|four|CD independent|independent|JJ lineages|lineage|NNS of|of|IN DA6192|da6192|NN (|(|-LRB- wild|wild|JJ type|type|NN )|)|-RRB- ,|,|, DA10826|da10826|NN (|(|-LRB- pmrA|pmra|NN )|)|-RRB- ,|,|, DA10840|da10840|NN (|(|-LRB- pmrA|pmra|NN )|)|-RRB- ,|,|, DA10833|da10833|NN (|(|-LRB- pmrB|pmrb|NN )|)|-RRB- ,|,|, and|and|CC DA10853|da10853|NN (|(|-LRB- pmrB|pmrb|NN )|)|-RRB- were|be|VBD inoculated|inoculate|VBN into|into|IN LB|LB|NNP broth|broth|NN .|.|. 
The|the|DT numbers|number|NNS of|of|IN viable|viable|JJ bacteria|bacterium|NNS at|at|IN different|different|JJ time|time|NN points|point|NNS were|be|VBD determined|determine|VBN by|by|IN plating|plating|NN samples|sample|NNS on|on|IN LA|LA|NNP plates|plate|NNS ,|,|, and|and|CC the|the|DT survival|survival|NN percentage|percentage|NN was|be|VBD calculated|calculate|VBN as|as|IN the|the|DT number|number|NN of|of|IN survivors|survivor|NNS divided|divide|VBN by|by|IN the|the|DT initial|initial|JJ number|number|NN of|of|IN colonies|colony|NNS in|in|IN each|each|DT culture|culture|NN (|(|-LRB- Fig.|fig.|NN 3|3|CD )|)|-RRB- .|.|. 
No|no|DT signiﬁcant|signiﬁcant|JJ differences|difference|NNS were|be|VBD observed|observe|VBN between|between|IN the|the|DT four|four|CD mutants|mutant|NNS and|and|CC the|the|DT wild|wild|JJ -|-|HYPH type|type|NN strain|strain|NN .|.|. 
The|the|DT number|number|NN of|of|IN viable|viable|JJ cells|cell|NNS decreased|decrease|VBD to|to|IN about|about|RB 0.2|0.2|CD to|to|IN 0.7|0.7|CD %|%|NN of|of|IN the|the|DT original|original|JJ population|population|NN in|in|IN 21|21|CD days|day|NNS .|.|. 
Fitness|fitness|NN of|of|IN resistant|resistant|JJ mutants|mutant|NNS during|during|IN growth|growth|NN in|in|IN mice|mouse|NNS .|.|. 
To|to|TO determine|determine|VB the|the|DT effects|effect|NNS of|of|IN the|the|DT pmrA|pmra|NN and|and|CC pmrB|pmrb|NN mutations|mutation|NNS on|on|IN ﬁtness|ﬁtness|NN in|in|IN mice|mouse|NNS ,|,|, we|we|PRP utilized|utilize|VBD an|a|DT in|in|FW vivo|vivo|FW competition|competition|NN assay|assay|NN .|.|. 
This|this|DT animal|animal|NN model|model|NN has|have|VBZ been|be|VBN used|use|VBN in|in|IN a|a|DT number|number|NN of|of|IN studies|study|NNS and|and|CC is|be|VBZ regarded|regard|VBN as|as|IN a|a|DT useful|useful|JJ model|model|NN to|to|TO assess|assess|VB bacterial|bacterial|JJ ﬁtness|ﬁtness|NN in|in|IN a|a|DT host|host|NN (|(|-LRB- 4|4|CD ,|,|, 5|5|CD ,|,|, 24|24|CD )|)|-RRB- .|.|. 
Approximately|approximately|RB equal|equal|JJ numbers|number|NNS of|of|IN mutant|mutant|NN and|and|CC wildtype|wildtype|JJ bacteria|bacterium|NNS were|be|VBD mixed|mix|VBN and|and|CC inoculated|inoculate|VBN intraperitoneally|intraperitoneally|RB into|into|IN ﬁve|ﬁve|NN mice|mouse|NNS .|.|. 
After|after|IN 3|3|CD days|day|NNS ,|,|, bacteria|bacterium|NNS were|be|VBD harvested|harvest|VBN from|from|IN the|the|DT spleens|spleen|NNS and|and|CC livers|liver|NNS of|of|IN the|the|DT mice|mouse|NNS and|and|CC plated|plate|VBN on|on|IN LA|LA|NNP and|and|CC LA|LA|NNP -|-|HYPH kanamycin|kanamycin|NN plates|plate|NNS to|to|TO determine|determine|VB the|the|DT number|number|NN of|of|IN mutant|mutant|NN versus|versus|CC wild|wild|JJ -|-|HYPH type|type|NN bacteria|bacterium|NNS .|.|. 
None|none|NN of|of|IN the|the|DT strains|strain|NNS DA10826|da10826|NN (|(|-LRB- pmrA|pmra|NN )|)|-RRB- ,|,|, DA10840|da10840|NN (|(|-LRB- pmrA|pmra|NN )|)|-RRB- ,|,|, DA10833|da10833|NN (|(|-LRB- pmrB|pmrb|NN )|)|-RRB- ,|,|, and|and|CC DA10853|da10853|NN (|(|-LRB- pmrB|pmrb|NN )|)|-RRB- showed|show|VBD any|any|DT signiﬁcant|signiﬁcant|JJ differences|difference|NNS in|in|IN ﬁtness|ﬁtness|NN compared|compare|VBN to|to|IN the|the|DT wild|wild|JJ type|type|NN (|(|-LRB- Table|table|NN 3|3|CD )|)|-RRB- .|.|. 
The|the|DT relatively|relatively|RB low|low|JJ (|(|-LRB- in|in|FW vitro|vitro|FW )|)|-RRB- or|or|CC absent|absent|JJ a|a|DT The|the|DT CI|ci|NN was|be|VBD calculated|calculate|VBN as|as|IN the|the|DT number|number|NN of|of|IN mutant|mutant|NN colonies|colony|NNS divided|divide|VBN by|by|IN the|the|DT number|number|NN of|of|IN wild|wild|JJ -|-|HYPH type|type|NN colonies|colony|NNS after|after|IN 10|10|CD generations|generation|NNS of|of|IN growth|growth|NN in|in|IN mice|mouse|NNS .|.|. 
The|the|DT growth|growth|NN rate|rate|NN of|of|IN the|the|DT wild|wild|JJ -|-|HYPH type|type|NN strain|strain|NN was|be|VBD set|set|VBN to|to|IN 1|1|CD ,|,|, and|and|CC the|the|DT relative|relative|JJ growth|growth|NN rates|rate|NNS of|of|IN the|the|DT mutants|mutant|NNS were|be|VBD calculated|calculate|VBN as|as|IN 1|1|CD s|s|NN (|(|-LRB- the|the|DT selection|selection|NN coefﬁcient|coefﬁcient|NN )|)|-RRB- ,|,|, where|where|WRB s|s|POS ln|ln|NN (|(|-LRB- CI|ci|NN )|)|-RRB- /|/|SYM 10|10|CD ln|ln|NN (|(|-LRB- 2|2|CD )|)|-RRB- .|.|. 
Amino|amino|NN acid|acid|NN substitutions|substitution|NNS in|in|IN the|the|DT mutants|mutant|NNS (|(|-LRB- using|use|VBG the|the|DT one|one|CD -|-|HYPH letter|letter|NN code|code|NN )|)|-RRB- are|be|VBP indicated|indicate|VBN 3|3|CD 4|4|CD 3|3|CD 3.5|3.5|CD 3.5|3.5|CD 3.5|3.5|CD 0.5|0.5|CD 0.25|0.25|CD 2.5|2.5|CD 4|4|CD 2.3|2.3|CD 2|2|CD 2.5|2.5|CD 3.5|3.5|CD 4.4|4.4|CD 3.5|3.5|CD 4|4|CD 2|2|CD 3|3|CD 3|3|CD 2.8|2.8|CD 2|2|CD 2|2|CD 2.7|2.7|CD 2.7|2.7|CD FIG.|fig.|NN 1|1|CD .|.|. 
Killing|killing|NN curves|curve|NNS for|for|IN the|the|DT wild|wild|JJ type|type|NN and|and|CC four|four|CD mutants|mutant|NNS with|with|IN reduced|reduce|VBN susceptibility|susceptibility|NN to|to|IN colistin|colistin|NN .|.|. 
CFU|CFU|NNP are|be|VBP plotted|plot|VBN as|as|IN a|a|DT function|function|NN of|of|IN time|time|NN for|for|IN different|different|JJ concentrations|concentration|NNS of|of|IN colistin|colistin|NN (|(|-LRB- 0.25|0.25|CD ,|,|, 1|1|CD ,|,|, 4|4|CD ,|,|, and|and|CC 16|16|CD mg|mg|NN /|/|SYM liter|liter|NN )|)|-RRB- .|.|. 
Amino|amino|NN acid|acid|NN substitutions|substitution|NNS in|in|IN the|the|DT mutants|mutant|NNS (|(|-LRB- using|use|VBG the|the|DT one|one|CD -|-|HYPH letter|letter|NN code|code|NN )|)|-RRB- are|be|VBP indicated|indicate|VBN as|as|IN follows|follow|VBZ :|:|: open|open|JJ circles|circle|NNS ,|,|, DA6192|da6192|NN (|(|-LRB- wild|wild|JJ type|type|NN )|)|-RRB- ;|;|: ﬁlled|ﬁlled|VBN diamonds|diamond|NNS ,|,|, DA10829|da10829|NN (|(|-LRB- PmrB|pmrb|NN [|[|-LRB- S29R|s29r|NN ]|]|-RRB- )|)|-RRB- ;|;|: open|open|JJ diamonds|diamond|NNS ,|,|, DA10845|da10845|NN (|(|-LRB- PmrB|pmrb|NN [|[|-LRB- M186I|m186i|NN ]|]|-RRB- )|)|-RRB- ;|;|: ﬁlled|ﬁlled|VBN triangles|triangle|NNS ,|,|, DA10826|da10826|NN (|(|-LRB- PmrA|pmra|NN [|[|-LRB- G53E|g53e|NN ]|]|-RRB- )|)|-RRB- ;|;|: open|open|JJ triangles|triangle|NNS ,|,|, DA10840|da10840|NN (|(|-LRB- PmrA|pmra|NN [|[|-LRB- R81H|r81h|NN ]|]|-RRB- )|)|-RRB- .|.|. 
TABLE|table|NN 2|2|CD .|.|. 
Susceptibilities|susceptibility|NNS of|of|IN mutants|mutant|NNS with|with|IN reduced|reduce|VBN susceptibility|susceptibility|NN to|to|IN colistin|colistin|NN to|to|IN different|different|JJ AMPs|amp|NNS MIC|MIC|NNP determined|determine|VBD in|in|IN liquid|liquid|JJ culturea|culturea|NN DA6192|da6192|NN (|(|-LRB- wild|wild|JJ type|type|NN )|)|-RRB- DA10826|da10826|NN (|(|-LRB- PmrA|pmra|NN G53E|g53e|NN )|)|-RRB- DA10833|da10833|NN (|(|-LRB- PmrB|pmrb|NN E166K|e166k|NN )|)|-RRB- DA10840|da10840|NN (|(|-LRB- PmrA|pmra|NN R81H|r81h|NN )|)|-RRB- DA10845|da10845|NN (|(|-LRB- PmrB|pmrb|NN M186I|m186i|NN )|)|-RRB- 12.5|12.5|CD M|m|NN 12.5|12.5|CD M|m|NN 12.5|12.5|CD M|m|NN 12.5|12.5|CD M|m|NN 12.5|12.5|CD M|m|NN 3|3|CD M|m|NN 3|3|CD M|m|NN 3|3|CD M|m|NN 3|3|CD M|m|NN 3|3|CD M|m|NN 31|31|CD mg|mg|NN /|/|SYM liter|liter|NN 31|31|CD mg|mg|NN /|/|SYM liter|liter|NN 31|31|CD mg|mg|NN /|/|SYM liter|liter|NN 31|31|CD mg|mg|NN /|/|SYM liter|liter|NN 31|31|CD mg|mg|NN /|/|SYM liter|liter|NN 0.19|0.19|CD mg|mg|NN /|/|SYM liter|liter|NN 0.19|0.19|CD mg|mg|NN /|/|SYM liter|liter|NN 0.19|0.19|CD mg|mg|NN /|/|SYM liter|liter|NN 0.19|0.19|CD mg|mg|NN /|/|SYM liter|liter|NN 0.19|0.19|CD mg|mg|NN /|/|SYM liter|liter|NN 15|15|CD M|m|NN 25|25|CD M|m|NN 25|25|CD M|m|NN 25|25|CD M|m|NN 25|25|CD M|m|NN Peptide|peptide|NN CNY|cny|NN 100|100|CD H|h|NN -|-|SYM L|l|NN PR|pr|NN -|-|HYPH 39|39|CD Protamine|protamine|NN sulfate|sulfate|NN Bleomycin|bleomycin|NN LL|ll|NN -|-|HYPH 37|37|CD a|a|DT Amino|amino|NN acid|acid|NN substitutions|substitution|NNS in|in|IN the|the|DT mutants|mutant|NNS (|(|-LRB- using|use|VBG the|the|DT one|one|CD -|-|HYPH letter|letter|NN code|code|NN )|)|-RRB- are|be|VBP indicated|indicate|VBN FIG.|fig.|NN 2|2|CD .|.|. 
Relative|relative|JJ growth|growth|NN rates|rate|NNS of|of|IN mutants|mutant|NNS with|with|IN reduced|reduce|VBN susceptibility|susceptibility|NN to|to|IN colistin|colistin|NN measured|measure|VBN in|in|IN LB|LB|NNP broth|broth|NN and|and|CC M9|m9|NN -|-|HYPH glycerol|glycerol|NN medium|medium|NN .|.|. 
The|the|DT growth|growth|NN rate|rate|NN for|for|IN each|each|DT strain|strain|NN was|be|VBD determined|determine|VBN from|from|IN four|four|CD to|to|IN eight|eight|CD independent|independent|JJ cultures|culture|NNS .|.|. 
The|the|DT standard|standard|JJ deviation|deviation|NN of|of|IN the|the|DT relative|relative|JJ growth|growth|NN rates|rate|NNS is|be|VBZ 2|2|CD %|%|NN .|.|. 
TABLE|table|NN 3|3|CD .|.|. 
CIs|ci|NNS and|and|CC relative|relative|JJ growth|growth|NN rates|rate|NNS of|of|IN strains|strain|NNS with|with|IN reduced|reduce|VBN susceptibility|susceptibility|NN to|to|IN colistin|colistin|NN in|in|IN micea|micea|NN Relative|relative|JJ growth|growth|NN rate|rate|NN CI|ci|NN Strains|strain|NNS FIG.|fig.|VBP 3|3|CD .|.|. 
Stationary|stationary|JJ -|-|HYPH phase|phase|NN survival|survival|NN of|of|IN four|four|CD strains|strain|NNS with|with|IN reduced|reduce|VBN susceptibility|susceptibility|NN to|to|IN colistin|colistin|NN compared|compare|VBN to|to|IN that|that|DT of|of|IN the|the|DT fully|fully|RB susceptible|susceptible|JJ strain|strain|NN .|.|. 
Four|four|CD independent|independent|JJ cultures|culture|NNS of|of|IN DA6192|da6192|NN (|(|-LRB- wild|wild|JJ type|type|NN )|)|-RRB- ,|,|, DA10826|da10826|NN (|(|-LRB- PmrA|pmra|NN [|[|-LRB- G53E|g53e|NN ]|]|-RRB- )|)|-RRB- ,|,|, DA10840|da10840|NN (|(|-LRB- PmrA|pmra|NN [|[|-LRB- R81H|r81h|NN ]|]|-RRB- )|)|-RRB- ,|,|, DA10833|da10833|NN (|(|-LRB- PmrB|pmrb|NN [|[|-LRB- E166K|e166k|NN ]|]|-RRB- )|)|-RRB- ,|,|, and|and|CC DA10853|da10853|NN (|(|-LRB- PmrB|pmrb|NN [|[|-LRB- N130Y|n130y|NN ]|]|-RRB- )|)|-RRB- were|be|VBD incubated|incubate|VBN at|at|IN 37|37|CD °C|°c|NN for|for|IN 21|21|CD days|day|NNS .|.|. 
The|the|DT survival|survival|NN percentage|percentage|NN was|be|VBD calculated|calculate|VBN as|as|IN the|the|DT average|average|JJ number|number|NN of|of|IN viable|viable|JJ cells|cell|NNS at|at|IN each|each|DT time|time|NN point|point|NN divided|divide|VBN by|by|IN the|the|DT number|number|NN of|of|IN viable|viable|JJ cells|cell|NNS at|at|IN the|the|DT start|start|NN of|of|IN the|the|DT experiment|experiment|NN .|.|. 
Amino|amino|NN acid|acid|NN substitutions|substitution|NNS in|in|IN the|the|DT mutants|mutant|NNS (|(|-LRB- using|use|VBG the|the|DT one|one|CD -|-|HYPH letter|letter|NN code|code|NN )|)|-RRB- are|be|VBP indicated|indicate|VBN as|as|IN follows|follow|VBZ :|:|: open|open|JJ circles|circle|NNS ,|,|, DA6192|da6192|NN (|(|-LRB- wild|wild|JJ type|type|NN )|)|-RRB- ;|;|: ﬁlled|ﬁlled|VBN triangles|triangle|NNS ,|,|, DA10826|da10826|NN (|(|-LRB- PmrA|pmra|NN [|[|-LRB- G53E|g53e|NN ]|]|-RRB- )|)|-RRB- ;|;|: open|open|JJ triangles|triangle|NNS ,|,|, DA10840|da10840|NN (|(|-LRB- PmrA|pmra|NN [|[|-LRB- R81H|r81h|NN ]|]|-RRB- )|)|-RRB- ;|;|: open|open|JJ diamonds|diamond|NNS ,|,|, DA10833|da10833|NN (|(|-LRB- PmrB|pmrb|NN [|[|-LRB- E166K|e166k|NN ]|]|-RRB- )|)|-RRB- ;|;|: ﬁlled|ﬁlled|VBN diamonds|diamond|NNS ,|,|, DA10853|da10853|NN (|(|-LRB- PmrB|pmrb|NN [|[|-LRB- N130Y|n130y|NN ]|]|-RRB- )|)|-RRB- .|.|. 
Spleen|spleen|NN Liver|liver|NN Spleen|spleen|NN Liver|liver|NN 0.91|0.91|CD 1.09|1.09|CD 1.00|1.00|CD 0.91|0.91|CD 0.93|0.93|CD 1.06|1.06|CD 1.03|1.03|CD 0.93|0.93|CD 0.55|0.55|CD 1.90|1.90|CD 1.00|1.00|CD 0.52|0.52|CD 0.60|0.60|CD 1.55|1.55|CD 1.21|1.21|CD 0.63|0.63|CD DA10826|da10826|NN (|(|-LRB- PmrA|pmra|NN G53E|g53e|NN )|)|-RRB- DA10840|da10840|NN (|(|-LRB- PmrA|pmra|NN R81H|r81h|NN )|)|-RRB- DA10833|da10833|NN (|(|-LRB- PmrB|pmrb|NN E166K|e166k|NN )|)|-RRB- DA10853|da10853|NN (|(|-LRB- PmrB|pmrb|NN N130Y|n130y|NN )|)|-RRB- (|(|-LRB- animal|animal|NN model|model|NN )|)|-RRB- ﬁtness|ﬁtness|NN cost|cost|NN of|of|IN the|the|DT pmrAB|pmrab|NN mutations|mutation|NNS and|and|CC the|the|DT high|high|JJ mutation|mutation|NN rate|rate|NN suggest|suggest|VBP that|that|IN mutants|mutant|NNS with|with|IN reduced|reduce|VBN susceptibility|susceptibility|NN to|to|IN colistin|colistin|NN may|may|MD be|be|VB selected|select|VBN for|for|IN in|in|IN clinical|clinical|JJ settings|setting|NNS ,|,|, which|which|WDT also|also|RB is|be|VBZ compatible|compatible|JJ with|with|IN the|the|DT current|current|JJ clinical|clinical|JJ situation|situation|NN (|(|-LRB- 3|3|CD ,|,|, 9|9|CD ,|,|, 13|13|CD ,|,|, 26|26|CD ,|,|, 31|31|CD ,|,|, 36|36|CD )|)|-RRB- .|.|. 
Expression|expression|NN level|level|NN of|of|IN the|the|DT pmrH|pmrh|NN gene|gene|NN .|.|. 
The|the|DT expression|expression|NN of|of|IN the|the|DT pmrH|pmrh|NN gene|gene|NN has|have|VBZ been|be|VBN shown|show|VBN to|to|TO be|be|VB regulated|regulate|VBN by|by|IN the|the|DT PmrA|pmra|NN -|-|HYPH PmrB|pmrb|NN two|two|CD -|-|HYPH component|component|NN regulatory|regulatory|JJ system|system|NN ,|,|, and|and|CC the|the|DT gene|gene|NN is|be|VBZ also|also|RB necessary|necessary|JJ for|for|IN conferring|confer|VBG PM|pm|NN resistance|resistance|NN (|(|-LRB- 7|7|CD )|)|-RRB- .|.|. 
We|we|PRP measured|measure|VBD the|the|DT expression|expression|NN levels|level|NNS of|of|IN the|the|DT pmrH|pmrh|NN gene|gene|NN for|for|IN 18|18|CD pmrB|pmrb|NN mutants|mutant|NNS and|and|CC 5|5|CD pmrA|pmra|NN mutants|mutant|NNS using|use|VBG real|real|JJ -|-|HYPH time|time|NN PCR|pcr|NN (|(|-LRB- Fig.|fig.|NN 4|4|CD )|)|-RRB- .|.|. 
Compared|compare|VBN with|with|IN the|the|DT wild|wild|JJ type|type|NN ,|,|, the|the|DT expression|expression|NN levels|level|NNS of|of|IN the|the|DT pmrH|pmrh|NN gene|gene|NN in|in|IN the|the|DT mutants|mutant|NNS with|with|IN reduced|reduce|VBN susceptibility|susceptibility|NN were|be|VBD increased|increase|VBN 2|2|CD -|-|HYPH to|to|IN 15-fold|15-fold|JJ ,|,|, showing|show|VBG that|that|IN the|the|DT pmrA|pmra|NN and|and|CC pmrB|pmrb|NN mutations|mutation|NNS changed|change|VBD the|the|DT regulation|regulation|NN of|of|IN the|the|DT PmrA|pmra|NN -|-|HYPH PmrB|pmrb|NN -|-|HYPH dependent|dependent|JJ genes|gene|NNS .|.|. 
There|there|EX was|be|VBD no|no|DT clear|clear|JJ correlation|correlation|NN between|between|IN the|the|DT expression|expression|NN level|level|NN of|of|IN the|the|DT pmrH|pmrh|NN gene|gene|NN and|and|CC the|the|DT MICs|mic|NNS for|for|IN colistin|colistin|NN of|of|IN the|the|DT set|set|NN of|of|IN mutants|mutant|NNS examined|examine|VBN .|.|. 
Since|since|IN the|the|DT PmrH|pmrh|NN enzyme|enzyme|NN is|be|VBZ only|only|RB one|one|CD of|of|IN several|several|JJ enzymes|enzyme|NNS required|require|VBN for|for|IN the|the|DT modiﬁcation|modiﬁcation|NN of|of|IN LPS|lps|NN and|and|CC the|the|DT pmrAB|pmrab|NN mutations|mutation|NNS might|might|MD affect|affect|VB the|the|DT expression|expression|NN levels|level|NNS of|of|IN these|these|DT other|other|JJ proteins|proteins|NN as|as|RB well|well|RB ,|,|, one|one|PRP would|would|MD not|not|RB necessarily|necessarily|RB expect|expect|VB a|a|DT direct|direct|JJ correlation|correlation|NN between|between|IN pmrH|pmrh|NN expression|expression|NN and|and|CC the|the|DT extent|extent|NN of|of|IN LPS|lps|NN modiﬁcation|modiﬁcation|NN (|(|-LRB- 8|8|CD )|)|-RRB- .|.|. 
In|in|IN addition|addition|NN ,|,|, the|the|DT small|small|JJ differences|difference|NNS between|between|IN the|the|DT MICs|mic|NNS of|of|IN colistin|colistin|NN for|for|IN the|the|DT different|different|JJ mutants|mutant|NNS could|could|MD also|also|RB make|make|VB it|it|PRP difﬁcult|difﬁcult|VB to|to|TO reveal|reveal|VB a|a|DT potential|potential|JJ correlation|correlation|NN .|.|. 
Identiﬁcation|identiﬁcation|NN of|of|IN the|the|DT domain|domain|NN locations|location|NNS of|of|IN the|the|DT mutations|mutation|NNS based|base|VBN on|on|IN homologous|homologous|JJ protein|protein|NN structure|structure|NN .|.|. 
PmrA|pmra|NN and|and|CC PmrB|pmrb|NN show|show|VBP homology|homology|NN with|with|IN other|other|JJ members|member|NNS of|of|IN two|two|CD -|-|HYPH component|component|NN regulatory|regulatory|JJ systems|system|NNS ,|,|, e.g.|e.g.|FW ,|,|, EnvZ|envz|NN -|-|HYPH OmpR|ompr|NN and|and|CC PhoR|phor|NN -|-|HYPH PhoB|phob|NN .|.|. 
By|by|IN combining|combine|VBG the|the|DT amino|amino|NN acid|acid|NN sequence|sequence|NN alignment|alignment|NN result|result|NN (|(|-LRB- between|between|IN PrmB|prmb|NN and|and|CC nine|nine|CD other|other|JJ homologous|homologous|JJ histidine|histidine|NN kinases|kinase|NNS [|[|-LRB- see|see|VB Fig|fig|NN .|.|. 
S1|s1|NN in|in|IN the|the|DT supplemental|supplemental|JJ material|material|NN ]|]|-RRB- )|)|-RRB- and|and|CC the|the|DT well|well|RB -|-|HYPH studied|study|VBN domains|domain|NNS of|of|IN EnvZ|envz|NN (|(|-LRB- 6|6|CD )|)|-RRB- ,|,|, PmrB|pmrb|NN was|be|VBD dissected|dissect|VBN into|into|IN six|six|CD domains|domain|NNS :|:|: TM1|tm1|NN (|(|-LRB- transmembrane|transmembrane|NN domain|domain|NN 1|1|CD )|)|-RRB- ,|,|, a|a|DT periplasmic|periplasmic|JJ domain|domain|NN ,|,|, TM2|tm2|NN ,|,|, a|a|DT linker|linker|NN (|(|-LRB- HAMP|hamp|NN )|)|-RRB- domain|domain|NN ,|,|, a|a|DT histidine|histidine|NN -|-|HYPH phosphotransfering|phosphotransfering|NN (|(|-LRB- HK|hk|NN )|)|-RRB- domain|domain|NN ,|,|, and|and|CC an|a|DT ATP|atp|NN -|-|HYPH binding|bind|VBG domain|domain|NN (|(|-LRB- Fig.|fig.|NN 5|5|CD )|)|-RRB- (|(|-LRB- 6|6|CD ,|,|, 23|23|CD )|)|-RRB- .|.|. 
The|the|DT residue|residue|NN numbers|number|NNS for|for|IN each|each|DT domain|domain|NN are|be|VBP shown|show|VBN in|in|IN Fig.|fig.|NN 5|5|CD .|.|. 
The|the|DT 16|16|CD mutated|mutate|VBN residues|residue|NNS in|in|IN the|the|DT pmrB|pmrb|NN mutants|mutant|NNS were|be|VBD distributed|distribute|VBN over|over|IN all|all|DT of|of|IN the|the|DT domains|domain|NNS except|except|IN the|the|DT periplasmic|periplasmic|JJ domain|domain|NN and|and|CC TM2|tm2|NN .|.|. 
In|in|IN several|several|JJ mutational|mutational|JJ studies|study|NNS of|of|IN EnvZ|envz|NN ,|,|, mutations|mutation|NNS in|in|IN the|the|DT TM1|tm1|NN domain|domain|NN ,|,|, the|the|DT HAMP|HAMP|NNP domain|domain|NN ,|,|, and|and|CC the|the|DT HK|hk|NN domain|domain|NN have|have|VBP been|be|VBN shown|show|VBN to|to|TO increase|increase|VB the|the|DT ratio|ratio|NN of|of|IN kinase|kinase|NN activity|activity|NN to|to|IN phosphatase|phosphatase|NN activity|activity|NN .|.|. 
In|in|IN this|this|DT work|work|NN ,|,|, we|we|PRP were|be|VBD able|able|JJ to|to|TO ﬁnd|ﬁnd|VB amino|amino|NN acid|acid|NN changes|change|NNS in|in|IN the|the|DT PmrB|pmrb|NN proteins|proteins|NN in|in|IN these|these|DT three|three|CD domains|domain|NNS ,|,|, as|as|RB well|well|RB as|as|IN two|two|CD mutations|mutation|NNS in|in|IN the|the|DT ATP|atp|NN -|-|HYPH binding|bind|VBG domain|domain|NN .|.|. 
Thus|thus|RB ,|,|, it|it|PRP is|be|VBZ possible|possible|JJ (|(|-LRB- even|even|RB though|though|IN not|not|RB experimentally|experimentally|RB demonstrated|demonstrate|VBN in|in|IN this|this|DT study|study|NN )|)|-RRB- that|that|IN the|the|DT mutations|mutation|NNS in|in|IN the|the|DT PmrB|pmrb|NN protein|protein|NN also|also|RB alter|alter|VB the|the|DT regulation|regulation|NN of|of|IN the|the|DT PmrA|pmra|NN -|-|HYPH PmrB|pmrb|NN regulatory|regulatory|JJ system|system|NN by|by|IN increasing|increase|VBG the|the|DT kinase|kinase|NN /|/|HYPH phosphatase|phosphatase|NN activity|activity|NN ratio|ratio|NN .|.|. 
Based|base|VBN on|on|IN the|the|DT alignment|alignment|NN data|datum|NNS between|between|IN PmrA|pmra|NN and|and|CC nine|nine|CD other|other|JJ homologous|homologous|JJ response|response|NN regulators|regulator|NNS (|(|-LRB- see|see|VB Fig|fig|NN .|.|. 
S1|s1|NN in|in|IN the|the|DT supplemental|supplemental|JJ material|material|NN )|)|-RRB- and|and|CC a|a|DT structural|structural|JJ study|study|NN of|of|IN the|the|DT PhoB|phob|NN protein|protein|NN (|(|-LRB- 32|32|CD )|)|-RRB- ,|,|, PmrA|pmra|NN was|be|VBD dissected|dissect|VBN into|into|IN two|two|CD domains|domain|NNS :|:|: the|the|DT phosphate|phosphate|NN receiver|receiver|NN domain|domain|NN and|and|CC the|the|DT DNA|dna|NN binding|bind|VBG domain|domain|NN .|.|. 
All|all|DT pmrA|pmra|NN mutations|mutation|NNS were|be|VBD located|locate|VBN in|in|IN the|the|DT phosphate|phosphate|NN receiver|receiver|NN domain|domain|NN ,|,|, in|in|IN the|the|DT vicinity|vicinity|NN of|of|IN the|the|DT Asp51|asp51|NN active|active|JJ site|site|NN (|(|-LRB- 32|32|CD )|)|-RRB- .|.|. 
Thus|thus|RB ,|,|, one|one|CD possible|possible|JJ rationalization|rationalization|NN for|for|IN the|the|DT effects|effect|NNS of|of|IN these|these|DT pmrA|pmra|NN mutations|mutation|NNS is|be|VBZ that|that|IN they|they|PRP prevent|prevent|VBP the|the|DT Asp|asp|NN active|active|JJ site|site|NN from|from|IN being|be|VBG dephosphorylated|dephosphorylate|VBN by|by|IN the|the|DT phosphatase|phosphatase|NN activity|activity|NN of|of|IN PmrB|pmrb|NN .|.|. 
FIG.|FIG.|NNP 4|4|CD .|.|. 
Relative|relative|JJ expression|expression|NN levels|level|NNS of|of|IN the|the|DT pmrH|pmrh|NN gene|gene|NN in|in|IN mutants|mutant|NNS with|with|IN reduced|reduce|VBN susceptibility|susceptibility|NN to|to|IN colistin|colistin|NN expressed|express|VBN as|as|IN mutant|mutant|NN /|/|HYPH wild|wild|JJ -|-|HYPH type|type|NN (|(|-LRB- wt|wt|NN )|)|-RRB- levels|level|NNS .|.|. 
Mutations|mutation|NNS in|in|IN the|the|DT pmrA|pmra|NN (|(|-LRB- gray|gray|JJ )|)|-RRB- and|and|CC pmrB|pmrb|NN (|(|-LRB- black|black|JJ )|)|-RRB- genes|gene|NNS are|be|VBP indicated|indicate|VBN .|.|. 
Amino|amino|NN acid|acid|NN substitutions|substitution|NNS in|in|IN the|the|DT mutants|mutant|NNS (|(|-LRB- using|use|VBG the|the|DT one|one|CD -|-|HYPH letter|letter|NN code|code|NN )|)|-RRB- are|be|VBP indicated|indicate|VBN .|.|. 
FIG.|FIG.|NNP 5|5|CD .|.|. 
Sequence|sequence|NN locations|location|NNS of|of|IN all|all|DT mutations|mutation|NNS conferring|confer|VBG colistin|colistin|NN resistance|resistance|NN and|and|CC the|the|DT MICs|mic|NNS of|of|IN colistin|colistin|NN for|for|IN the|the|DT corresponding|correspond|VBG mutants|mutant|NNS .|.|. 
Mutations|mutation|NNS in|in|IN pmrA|pmra|NN (|(|-LRB- gray|gray|JJ )|)|-RRB- and|and|CC pmrB|pmrb|NN (|(|-LRB- black|black|JJ )|)|-RRB- and|and|CC amino|amino|NN acid|acid|NN substitutions|substitution|NNS in|in|IN the|the|DT mutants|mutant|NNS (|(|-LRB- using|use|VBG the|the|DT one|one|CD -|-|HYPH letter|letter|NN code|code|NN )|)|-RRB- are|be|VBP indicated|indicate|VBN ACKNOWLEDGMENTS|acknowledgment|NNS This|this|DT work|work|NN was|be|VBD supported|support|VBN by|by|IN grants|grant|NNS from|from|IN the|the|DT Swedish|Swedish|NNP Research|Research|NNP Council|Council|NNP ,|,|, Söderberg|Söderberg|NNP 's|'s|POS Foundation|Foundation|NNP ,|,|, and|and|CC the|the|DT EU|EU|NNP 6th|6th|NN Framework|Framework|NNP Programme|Programme|NNP to|to|IN D.I.A.|D.I.A.|NNP .|.|. 
We|we|PRP thank|thank|VBP Linus|Linus|NNP Sandegren|Sandegren|NNP for|for|IN comments|comment|NNS on|on|IN the|the|DT manuscript|manuscript|NN .|.|. 
REFERENCES|reference|NNS 1|1|CD .|.|. 
Adams|Adams|NNP ,|,|, M.|M.|NNP D.|D.|NNP 2008|2008|CD .|.|. 
Resistance|resistance|NN to|to|IN colistin|colistin|NN in|in|IN Acinetobacter|Acinetobacter|NNP baumannii|baumannii|NNP mediated|mediate|VBN by|by|IN the|the|DT PmrBA|PmrBA|NNP two|two|CD -|-|HYPH component|component|NN system|system|NN .|.|. 
Abstr|Abstr|NNP .|.|. 
48th|48th|JJ Intersci|Intersci|NNP .|.|. 
Conf|conf|NN .|.|. 
Antimicrob|Antimicrob|NNP .|.|. 
Agents|agent|NNS Chemother|Chemother|NNP .|.|. 
,|,|, abstr|abstr|NN .|.|. 
C2|c2|NN -|-|HYPH 3871a|3871a|NN .|.|. 
2|2|LS .|.|. 
Andersson|Andersson|NNP ,|,|, D.|D.|NNP I.|I.|NNP 2006|2006|CD .|.|. 
The|the|DT biological|biological|JJ cost|cost|NN of|of|IN mutational|mutational|JJ antibiotic|antibiotic|JJ resistance|resistance|NN :|:|: any|any|DT practical|practical|JJ conclusions|conclusion|NNS ?|?|. 
Curr|Curr|NNP .|.|. 
Opin|Opin|NNP .|.|. 
Microbiol|Microbiol|NNP .|.|. 
9:461|9:461|CD --|--|: 465|465|CD .|.|. 
3|3|LS .|.|. 
Antoniadou|Antoniadou|NNP ,|,|, A.|A.|NNP ,|,|, F.|F.|NNP Kontopidou|Kontopidou|NNP ,|,|, G.|G.|NNP Poulakou|Poulakou|NNP ,|,|, E.|E.|NNP Koratzanis|Koratzanis|NNP ,|,|, I.|I.|NNP Galani|Galani|NNP ,|,|, E.|E.|NNP Papadomichelakis|Papadomichelakis|NNP ,|,|, P.|P.|NNP Kopterides|Kopterides|NNP ,|,|, M.|M.|NNP Souli|Souli|NNP ,|,|, A.|A.|NNP Armaganidis|Armaganidis|NNP ,|,|, and|and|CC H.|H.|NNP Giamarellou|Giamarellou|NNP .|.|. 
2007|2007|CD .|.|. 
Colistin|colistin|NN -|-|HYPH resistant|resistant|JJ isolates|isolate|VBZ of|of|IN Klebsiella|klebsiella|NN pneumoniae|pneumonia|NNS emerging|emerge|VBG in|in|IN intensive|intensive|JJ care|care|NN unit|unit|NN patients|patient|NNS :|:|: ﬁrst|ﬁrst|JJ report|report|NN of|of|IN a|a|DT multiclonal|multiclonal|JJ cluster|cluster|NN .|.|. 
J.|J.|NNP Antimicrob|Antimicrob|NNP .|.|. 
Chemother|Chemother|NNP .|.|. 
59:786|59:786|CD --|--|: 790|790|CD .|.|. 
4|4|LS .|.|. 
Björkman|Björkman|NNP ,|,|, J.|J.|NNP ,|,|, D.|D.|NNP Hughes|Hughes|NNP ,|,|, and|and|CC D.|D.|NNP I.|I.|NNP Andersson|Andersson|NNP .|.|. 
1998|1998|CD .|.|. 
Virulence|virulence|NN of|of|IN antibiotic|antibiotic|JJ -|-|HYPH resistant|resistant|JJ Salmonella|salmonella|NN typhimurium|typhimurium|NN .|.|. 
Proc|Proc|NNP .|.|. 
Natl.|Natl.|NNP Acad|Acad|NNP .|.|. 
Sci|sci|NN .|.|. 
USA|USA|NNP 95:3949|95:3949|CD --|--|: 3953|3953|CD .|.|. 
5|5|CD .|.|. 
Björkman|Björkman|NNP ,|,|, J.|J.|NNP ,|,|, I.|I.|NNP Nagaev|Nagaev|NNP ,|,|, O.|O.|NNP G.|G.|NNP Berg|Berg|NNP ,|,|, D.|D.|NNP Hughes|Hughes|NNP ,|,|, and|and|CC D.|D.|NNP I.|I.|NNP Andersson|Andersson|NNP .|.|. 
2000|2000|CD .|.|. 
Effects|Effects|NNPS of|of|IN environment|environment|NN on|on|IN compensatory|compensatory|JJ mutations|mutation|NNS to|to|TO ameliorate|ameliorate|VB costs|cost|NNS of|of|IN antibiotic|antibiotic|JJ resistance|resistance|NN .|.|. 
Science|Science|NNP 287:1479|287:1479|CD --|--|: 1482|1482|CD .|.|. 
6|6|CD .|.|. 
Dutta|Dutta|NNP ,|,|, R.|R.|NNP ,|,|, T.|T.|NNP Yoshida|Yoshida|NNP ,|,|, and|and|CC M.|M.|NNP Inouye|Inouye|NNP .|.|. 
2000|2000|CD .|.|. 
The|the|DT critical|critical|JJ role|role|NN of|of|IN the|the|DT conserved|conserve|VBN Thr247|thr247|NN residue|residue|NN in|in|IN the|the|DT functioning|functioning|NN of|of|IN the|the|DT osmosensor|osmosensor|NN EnvZ|envz|NN ,|,|, a|a|DT histidine|histidine|NN kinase|kinase|NN /|/|HYPH phosphatase|phosphatase|NN ,|,|, in|in|IN Escherichia|Escherichia|NNP coli|coli|NNP .|.|. 
J.|J.|NNP Biol|Biol|NNP .|.|. 
Chem|Chem|NNP .|.|. 
275:38645|275:38645|CD --|--|: 38653|38653|CD .|.|. 
7|7|CD .|.|. 
Gunn|Gunn|NNP ,|,|, J.|J.|NNP S.|S.|NNP ,|,|, K.|K.|NNP B.|B.|NNP Lim|Lim|NNP ,|,|, J.|J.|NNP Krueger|Krueger|NNP ,|,|, K.|K.|NNP Kim|Kim|NNP ,|,|, L.|L.|NNP Guo|Guo|NNP ,|,|, M.|M.|NNP Hackett|Hackett|NNP ,|,|, and|and|CC S.|S.|NNP I.|I.|NNP Miller|Miller|NNP .|.|. 
1998|1998|CD .|.|. 
PmrA|pmra|NN -|-|HYPH PmrB|pmrb|NN -|-|HYPH regulated|regulate|VBN genes|gene|NNS necessary|necessary|JJ for|for|IN 4|4|CD -|-|HYPH aminoarabinose|aminoarabinose|NN lipid|lipid|NN A|a|DT modiﬁcation|modiﬁcation|NN and|and|CC polymyxin|polymyxin|NN resistance|resistance|NN .|.|. 
Mol|Mol|NNP .|.|. 
Microbiol|Microbiol|NNP .|.|. 
27:1171|27:1171|CD --|--|: 1182|1182|CD .|.|. 
8|8|CD .|.|. 
Gunn|Gunn|NNP ,|,|, J.|J.|NNP S.|S.|NNP ,|,|, S.|S.|NNP S.|S.|NNP Ryan|Ryan|NNP ,|,|, J.|J.|NNP C.|C.|NNP Van|Van|NNP Velkinburgh|Velkinburgh|NNP ,|,|, R.|R.|NNP K.|K.|NNP Ernst|Ernst|NNP ,|,|, and|and|CC S.|S.|NNP I.|I.|NNP Miller|Miller|NNP .|.|. 
2000|2000|CD .|.|. 
Genetic|genetic|JJ and|and|CC functional|functional|JJ analysis|analysis|NN of|of|IN a|a|DT PmrA|pmra|NN -|-|HYPH PmrB|pmrb|NN -|-|HYPH regulated|regulate|VBN locus|locus|NN necessary|necessary|JJ for|for|IN lipopolysaccharide|lipopolysaccharide|NN modiﬁcation|modiﬁcation|NN ,|,|, antimicrobial|antimicrobial|JJ peptide|peptide|NN resistance|resistance|NN ,|,|, and|and|CC oral|oral|JJ virulence|virulence|NN of|of|IN Salmonella|Salmonella|NNP enterica|enterica|NNP serovar|serovar|NNP Typhimurium|Typhimurium|NNP .|.|. 
Infect|infect|VB .|.|. 
Immun|Immun|NNP .|.|. 
68:6139|68:6139|CD --|--|: 6146|6146|CD .|.|. 
9|9|LS .|.|. 
Hawley|Hawley|NNP ,|,|, J.|J.|NNP S.|S.|NNP ,|,|, C.|C.|NNP K.|K.|NNP Murray|Murray|NNP ,|,|, and|and|CC J.|J.|NNP H.|H.|NNP Jorgensen|Jorgensen|NNP .|.|. 
2008|2008|CD .|.|. 
Colistin|Colistin|NNP heteroresistance|heteroresistance|NN in|in|IN Acinetobacter|Acinetobacter|NNP and|and|CC its|its|PRP$ association|association|NN with|with|IN previous|previous|JJ colistin|colistin|NN therapy|therapy|NN .|.|. 
Antimicrob|Antimicrob|NNP .|.|. 
Agents|agent|NNS Chemother|Chemother|NNP .|.|. 
52:351|52:351|CD --|--|: 352|352|CD .|.|. 
10|10|CD .|.|. 
Jensen|Jensen|NNP ,|,|, T.|T.|NNP ,|,|, S.|S.|NNP S.|S.|NNP Pedersen|Pedersen|NNP ,|,|, S.|S.|NNP Garne|Garne|NNP ,|,|, C.|C.|NNP Heilmann|Heilmann|NNP ,|,|, N.|N.|NNP Høiby|Høiby|NNP ,|,|, and|and|CC C.|C.|NNP Koch|Koch|NNP .|.|. 
1987|1987|CD .|.|. 
Colistin|Colistin|NNP inhalation|inhalation|NN therapy|therapy|NN in|in|IN cystic|cystic|JJ ﬁbrosis|ﬁbrosis|NN patients|patient|NNS with|with|IN chronic|chronic|JJ Pseudomonas|Pseudomonas|NNP aeruginosa|aeruginosa|NN lung|lung|NN infection|infection|NN .|.|. 
J.|J.|NNP Antimicrob|Antimicrob|NNP .|.|. 
Chemother|Chemother|NNP .|.|. 
19:831|19:831|CD --|--|: 838|838|CD .|.|. 
11|11|CD .|.|. 
Karabinis|Karabinis|NNP ,|,|, A.|A.|NNP ,|,|, E.|E.|NNP Paramythiotou|Paramythiotou|NNP ,|,|, D.|D.|NNP Mylona|Mylona|NNP -|-|HYPH Petropoulou|Petropoulou|NNP ,|,|, A.|A.|NNP Kalogero|Kalogero|NNP -|-|HYPH mitros|mitros|NNP ,|,|, N.|N.|NNP Katsarelis|Katsarelis|NNP ,|,|, F.|F.|NNP Kontopidou|Kontopidou|NNP ,|,|, I.|I.|NNP Poularas|Poularas|NNP ,|,|, and|and|CC H.|H.|NNP Malamou|Malamou|NNP -|-|HYPH Lada|Lada|NNP .|.|. 
2004|2004|CD .|.|. 
Colistin|Colistin|NNP for|for|IN Klebsiella|Klebsiella|NNP pneumoniae|pneumoniae|NN -|-|HYPH associated|associate|VBN sepsis|sepsis|NN .|.|. 
Clin|clin|NN .|.|. 
Infect|infect|VB .|.|. 
Dis|Dis|NNP .|.|. 
38|38|CD :|:|: e7|e7|NN --|--|: e9|e9|NN .|.|. 
12|12|CD .|.|. 
Kasiakou|Kasiakou|NNP ,|,|, S.|S.|NNP K.|K.|NNP ,|,|, A.|A.|NNP Michalopoulos|Michalopoulos|NNP ,|,|, E.|E.|NNP S.|S.|NNP Soteriades|Soteriades|NNP ,|,|, G.|G.|NNP Samonis|Samonis|NNP ,|,|, G.|G.|NNP J.|J.|NNP Sermaides|Sermaides|NNP ,|,|, and|and|CC M.|M.|NNP E.|E.|NNP Falagas|Falagas|NNP .|.|. 
2005|2005|CD .|.|. 
Combination|combination|NN therapy|therapy|NN with|with|IN intravenous|intravenous|JJ colistin|colistin|NN for|for|IN management|management|NN of|of|IN infections|infection|NNS due|due|IN to|to|IN multidrug|multidrug|JJ -|-|HYPH resistant|resistant|JJ gram|gram|NN -|-|HYPH neg|neg|NN -|-|HYPH ative|ative|JJ bacteria|bacterium|NNS in|in|IN patients|patient|NNS without|without|IN cystic|cystic|JJ ﬁbrosis|ﬁbrosis|NN .|.|. 
Antimicrob|Antimicrob|NNP .|.|. 
Agents|agent|NNS Che|Che|NNP -|-|HYPH mother|mother|NN .|.|. 
49:3136|49:3136|CD --|--|: 3146|3146|CD .|.|. 
13|13|CD .|.|. 
Ko|Ko|NNP ,|,|, K.|K.|NNP S.|S.|NNP ,|,|, J.|J.|NNP Y.|Y.|NNP Suh|Suh|NNP ,|,|, K.|K.|NNP T.|T.|NNP Kwon|Kwon|NNP ,|,|, S.|S.|NNP I.|I.|NNP Jung|Jung|NNP ,|,|, K.|K.|NNP H.|H.|NNP Park|Park|NNP ,|,|, C.|C.|NNP I.|I.|NNP Kang|Kang|NNP ,|,|, D.|D.|NNP R.|R.|NNP Chung|Chung|NNP ,|,|, K.|K.|NNP R.|R.|NNP Peck|Peck|NNP ,|,|, and|and|CC J.|J.|NNP H.|H.|NNP Song|Song|NNP .|.|. 
2007|2007|CD .|.|. 
High|high|JJ rates|rate|NNS of|of|IN resistance|resistance|NN to|to|IN colistin|colistin|NN and|and|CC polymyxin|polymyxin|NN B|b|NN in|in|IN subgroups|subgroup|NNS of|of|IN Acinetobacter|Acinetobacter|NNP baumannii|baumannii|NNP isolates|isolate|VBZ from|from|IN Korea|Korea|NNP .|.|. 
J.|J.|NNP Antimicrob|Antimicrob|NNP .|.|. 
Chemother|Chemother|NNP .|.|. 
60:1163|60:1163|CD --|--|: 1167|1167|CD .|.|. 
14|14|CD .|.|. 
Koch|Koch|NNP -|-|HYPH Weser|Weser|NNP ,|,|, J.|J.|NNP ,|,|, V.|V.|NNP W.|W.|NNP Sidel|Sidel|NNP ,|,|, E.|E.|NNP B.|B.|NNP Federman|Federman|NNP ,|,|, P.|P.|NNP Kanarek|Kanarek|NNP ,|,|, D.|D.|NNP C.|C.|NNP Finer|Finer|NNP ,|,|, and|and|CC A.|A.|NNP E.|E.|NNP Eaton|Eaton|NNP .|.|. 
1970|1970|CD .|.|. 
Adverse|adverse|JJ effects|effect|NNS of|of|IN sodium|sodium|NN colistimethate|colistimethate|NN .|.|. 
Manifestations|manifestation|NNS and|and|CC speciﬁc|speciﬁc|JJ reaction|reaction|NN rates|rate|NNS during|during|IN 317|317|CD courses|course|NNS of|of|IN therapy|therapy|NN .|.|. 
Ann|Ann|NNP .|.|. 
Intern|intern|NN .|.|. 
Med|Med|NNP .|.|. 
72:857|72:857|CD --|--|: 868|868|CD .|.|. 
15|15|CD .|.|. 
Lea|Lea|NNP ,|,|, D.|D.|NNP E.|E.|NNP ,|,|, and|and|CC C.|C.|NNP A.|A.|NNP Coulson|Coulson|NNP .|.|. 
1949|1949|CD .|.|. 
The|the|DT distribution|distribution|NN of|of|IN the|the|DT numbers|number|NNS of|of|IN mutants|mutant|NNS in|in|IN bacterial|bacterial|JJ populations|population|NNS .|.|. 
J.|J.|NNP Genet|Genet|NNP .|.|. 
49:264|49:264|CD --|--|: 285|285|CD .|.|. 
16|16|CD .|.|. 
Lee|Lee|NNP ,|,|, H.|H.|NNP ,|,|, F.|F.|NNP F.|F.|NNP Hsu|Hsu|NNP ,|,|, J.|J.|NNP Turk|Turk|NNP ,|,|, and|and|CC E.|E.|NNP A.|A.|NNP Groisman|Groisman|NNP .|.|. 
2004|2004|CD .|.|. 
The|the|DT PmrA|pmra|NN -|-|HYPH regulated|regulate|VBN pmrC|pmrc|NN gene|gene|NN mediates|mediate|VBZ phosphoethanolamine|phosphoethanolamine|NN modiﬁcation|modiﬁcation|NN of|of|IN lipid|lipid|NN A|a|NN and|and|CC poly|poly|NN -|-|HYPH myxin|myxin|NN resistance|resistance|NN in|in|IN Salmonella|Salmonella|NNP enterica|enterica|NNP .|.|. 
J.|J.|NNP Bacteriol|Bacteriol|NNP .|.|. 
186:4124|186:4124|CD --|--|: 4133|4133|CD .|.|. 
17|17|CD .|.|. 
Levin|Levin|NNP ,|,|, A.|A.|NNP S.|S.|NNP ,|,|, A.|A.|NNP A.|A.|NNP Barone|Barone|NNP ,|,|, J.|J.|NNP Penço|Penço|NNP ,|,|, M.|M.|NNP V.|V.|NNP Santos|Santos|NNP ,|,|, I.|I.|NNP S.|S.|NNP Marinho|Marinho|NNP ,|,|, E.|E.|NNP A.|A.|NNP Arruda|Arruda|NNP ,|,|, E.|E.|NNP I.|I.|NNP Manrique|Manrique|NNP ,|,|, and|and|CC S.|S.|NNP F.|F.|NNP Costa|Costa|NNP .|.|. 
1999|1999|CD .|.|. 
Intravenous|intravenous|JJ colistin|colistin|NN as|as|IN therapy|therapy|NN for|for|IN nosocomial|nosocomial|JJ infections|infection|NNS caused|cause|VBN by|by|IN multidrug|multidrug|JJ -|-|HYPH resistant|resistant|JJ Pseudomo|pseudomo|NN -|-|HYPH nas|na|NNS aeruginosa|aeruginosa|NN and|and|CC Acinetobacter|Acinetobacter|NNP baumannii|baumannii|NNP .|.|. 
Clin|clin|NN .|.|. 
Infect|infect|VB .|.|. 
Dis|Dis|NNP .|.|. 
28:1008|28:1008|CD --|--|: 1011|1011|CD .|.|. 
18|18|CD .|.|. 
Mäkelä|Mäkelä|NNP ,|,|, P.|P.|NNP H.|H.|NNP ,|,|, M.|M.|NNP Sarvas|Sarvas|NNP ,|,|, S.|S.|NNP Calcagno|Calcagno|NNP ,|,|, and|and|CC K.|K.|NNP Lounatmaa|Lounatmaa|NNP .|.|. 
1978|1978|CD .|.|. 
Isolation|isolation|NN and|and|CC genetic|genetic|JJ characterization|characterization|NN of|of|IN polymyxin|polymyxin|NN -|-|HYPH resistant|resistant|JJ mutants|mutant|NNS of|of|IN Salmonella|Salmonella|NNP .|.|. 
FEMS|FEMS|NNP Microbiol|Microbiol|NNP .|.|. 
Lett|Lett|NNP .|.|. 
3:323|3:323|CD --|--|: 326|326|CD .|.|. 
19|19|CD .|.|. 
Michalopoulos|Michalopoulos|NNP ,|,|, A.|A.|NNP S.|S.|NNP ,|,|, S.|S.|NNP Tsiodras|Tsiodras|NNP ,|,|, K.|K.|NNP Rellos|Rellos|NNP ,|,|, S.|S.|NNP Mentzelopoulos|Mentzelopoulos|NNP ,|,|, and|and|CC M.|M.|NNP E.|E.|NNP Falagas|Falagas|NNP .|.|. 
2005|2005|CD .|.|. 
Colistin|colistin|NN treatment|treatment|NN in|in|IN patients|patient|NNS with|with|IN ICU|icu|NN -|-|HYPH acquired|acquire|VBN infections|infection|NNS caused|cause|VBN by|by|IN multiresistant|multiresistant|JJ Gram|Gram|NNP -|-|HYPH negative|negative|JJ bacteria|bacterium|NNS :|:|: the|the|DT renaissance|renaissance|NN of|of|IN an|a|DT old|old|JJ antibiotic|antibiotic|NN .|.|. 
Clin|clin|NN .|.|. 
Microbiol|Microbiol|NNP .|.|. 
Infect|infect|VB .|.|. 
11:115|11:115|CD --|--|: 121|121|CD .|.|. 
20|20|CD .|.|. 
Moskowitz|Moskowitz|NNP ,|,|, S.|S.|NNP M.|M.|NNP ,|,|, R.|R.|NNP K.|K.|NNP Ernst|Ernst|NNP ,|,|, and|and|CC S.|S.|NNP I.|I.|NNP Miller|Miller|NNP .|.|. 
2004|2004|CD .|.|. 
PmrAB|PmrAB|NNP ,|,|, a|a|DT two|two|CD -|-|HYPH component|component|NN regulatory|regulatory|JJ system|system|NN of|of|IN Pseudomonas|Pseudomonas|NNP aeruginosa|aeruginosa|NNP that|that|WDT modulates|modulate|VBZ resistance|resistance|NN to|to|IN cationic|cationic|JJ antimicrobial|antimicrobial|JJ peptides|peptide|NNS and|and|CC addition|addition|NN of|of|IN aminoarabinose|aminoarabinose|NN to|to|IN lipid|lipid|NN A.|A.|NNP J.|J.|NNP Bacteriol|Bacteriol|NNP .|.|. 
186:575|186:575|CD --|--|: 579|579|CD .|.|. 
21|21|CD .|.|. 
Newton|Newton|NNP ,|,|, B.|B.|NNP A.|A.|NNP 1956|1956|CD .|.|. 
The|the|DT properties|property|NNS and|and|CC mode|mode|NN of|of|IN action|action|NN of|of|IN the|the|DT polymyxins|polymyxin|NNS .|.|. 
Bacteriol|Bacteriol|NNP .|.|. 
Rev.|Rev.|NNP 20:14|20:14|CD --|--|: 27|27|CD .|.|. 
22|22|CD .|.|. 
Nilsson|Nilsson|NNP ,|,|, A.|A.|NNP I.|I.|NNP ,|,|, E.|E.|NNP Kugelberg|Kugelberg|NNP ,|,|, O.|O.|NNP G.|G.|NNP Berg|Berg|NNP ,|,|, and|and|CC D.|D.|NNP I.|I.|NNP Andersson|Andersson|NNP .|.|. 
2004|2004|CD .|.|. 
Experimental|experimental|JJ adaptation|adaptation|NN of|of|IN Salmonella|Salmonella|NNP typhimurium|typhimurium|NN to|to|IN mice|mouse|NNS .|.|. 
Genetics|Genetics|NNP 168:1119|168:1119|CD --|--|: 1130|1130|CD .|.|. 
23|23|CD .|.|. 
Park|Park|NNP ,|,|, H.|H.|NNP ,|,|, S.|S.|NNP K.|K.|NNP Saha|Saha|NNP ,|,|, and|and|CC M.|M.|NNP Inouye|Inouye|NNP .|.|. 
1998|1998|CD .|.|. 
Two|two|CD -|-|HYPH domain|domain|NN reconstitution|reconstitution|NN of|of|IN a|a|DT functional|functional|JJ protein|protein|NN histidine|histidine|NN kinase|kinase|NN .|.|. 
Proc|Proc|NNP .|.|. 
Natl.|Natl.|NNP Acad|Acad|NNP .|.|. 
Sci|sci|NN .|.|. 
USA|USA|NNP 95:6728|95:6728|CD --|--|: 6732|6732|CD .|.|. 
24|24|CD .|.|. 
Paulander|Paulander|NNP ,|,|, W.|W.|NNP ,|,|, A.|A.|NNP Pennhag|Pennhag|NNP ,|,|, D.|D.|NNP I.|I.|NNP Andersson|Andersson|NNP ,|,|, and|and|CC S.|S.|NNP Maisnier|Maisnier|NNP -|-|HYPH Patin|Patin|NNP .|.|. 
2007|2007|CD .|.|. 
Caenorhabditis|Caenorhabditis|NNP elegans|elegans|NNP as|as|IN a|a|DT model|model|NN to|to|TO determine|determine|VB ﬁtness|ﬁtness|NN of|of|IN antibiotic|antibiotic|JJ -|-|HYPH resistant|resistant|JJ Salmonella|salmonella|NN enterica|enterica|NN serovar|serovar|NN Typhimurium|typhimurium|NN .|.|. 
Antimicrob|Antimicrob|NNP .|.|. 
Agents|agent|NNS Chemother|Chemother|NNP .|.|. 
51:766|51:766|CD --|--|: 769|769|CD .|.|. 
25|25|CD .|.|. 
Pintado|Pintado|NNP ,|,|, V.|V.|NNP ,|,|, L.|L.|NNP G.|G.|NNP San|San|NNP Miguel|Miguel|NNP ,|,|, F.|F.|NNP Grill|Grill|NNP ,|,|, B.|B.|NNP Mejıa|Mejıa|NNP ,|,|, J.|J.|NNP Cobo|Cobo|NNP ,|,|, J.|J.|NNP Fortœn|Fortœn|NNP ,|,|, P.|P.|NNP Martín|Martín|NNP -|-|HYPH Da|Da|NNP ́vila|́vila|NNP ,|,|, and|and|CC S.|S.|NNP Moreno|Moreno|NNP .|.|. 
2008|2008|CD .|.|. 
Intravenous|intravenous|JJ colistin|colistin|NN sulphomethate|sulphomethate|NN sodium|sodium|NN for|for|IN therapy|therapy|NN of|of|IN infections|infection|NNS due|due|IN to|to|IN multidrug|multidrug|JJ -|-|HYPH resistant|resistant|JJ gram|gram|NN -|-|HYPH negative|negative|JJ bacteria|bacterium|NNS .|.|. 
J.|J.|NNP Infect|Infect|NNP .|.|. 
56:185|56:185|CD --|--|: 190|190|CD .|.|. 
26|26|CD .|.|. 
Pitt|Pitt|NNP ,|,|, T.|T.|NNP L.|L.|NNP ,|,|, M.|M.|NNP Sparrow|Sparrow|NNP ,|,|, M.|M.|NNP Warner|Warner|NNP ,|,|, and|and|CC M.|M.|NNP Stefanidou|Stefanidou|NNP .|.|. 
2003|2003|CD .|.|. 
Survey|Survey|NNP of|of|IN resistance|resistance|NN of|of|IN Pseudomonas|Pseudomonas|NNP aeruginosa|aeruginosa|NNP from|from|IN UK|UK|NNP patients|patient|NNS with|with|IN cystic|cystic|JJ ﬁbrosis|ﬁbrosis|NN to|to|IN six|six|CD commonly|commonly|RB prescribed|prescribe|VBN antimicrobial|antimicrobial|JJ agents|agent|NNS .|.|. 
Thorax|Thorax|NNP 58:794|58:794|CD --|--|: 796|796|CD .|.|. 
27|27|CD .|.|. 
Pope|Pope|NNP ,|,|, C.|C.|NNP F.|F.|NNP ,|,|, D.|D.|NNP M.|M.|NNP O'Sullivan|O'Sullivan|NNP ,|,|, T.|T.|NNP D.|D.|NNP McHugh|McHugh|NNP ,|,|, and|and|CC S.|S.|NNP H.|H.|NNP Gillespie|Gillespie|NNP .|.|. 
2008|2008|CD .|.|. 
A|a|DT practical|practical|JJ guide|guide|NN to|to|IN measuring|measure|VBG mutation|mutation|NN rates|rate|NNS in|in|IN antibiotic|antibiotic|JJ resistance|resistance|NN .|.|. 
Antimicrob|Antimicrob|NNP .|.|. 
Agents|agent|NNS Chemother|Chemother|NNP .|.|. 
52:1209|52:1209|CD --|--|: 1214|1214|CD .|.|. 
28|28|CD .|.|. 
Roland|Roland|NNP ,|,|, K.|K.|NNP L.|L.|NNP ,|,|, L.|L.|NNP E.|E.|NNP Martin|Martin|NNP ,|,|, C.|C.|NNP R.|R.|NNP Esther|Esther|NNP ,|,|, and|and|CC J.|J.|NNP K.|K.|NNP Spitznagel|Spitznagel|NNP .|.|. 
1993|1993|CD .|.|. 
Spontaneous|spontaneous|JJ pmrA|pmra|NN mutants|mutant|NNS of|of|IN Salmonella|Salmonella|NNP typhimurium|typhimurium|NN LT2|lt2|NN deﬁne|deﬁne|NN a|a|DT new|new|JJ two|two|CD -|-|HYPH component|component|NN regulatory|regulatory|JJ system|system|NN with|with|IN a|a|DT possible|possible|JJ role|role|NN in|in|IN virulence|virulence|NN .|.|. 
J.|J.|NNP Bacteriol|Bacteriol|NNP .|.|. 
175:4154|175:4154|CD --|--|: 4164|4164|CD .|.|. 
29|29|CD .|.|. 
Sarkar|Sarkar|NNP ,|,|, S.|S.|NNP ,|,|, E.|E.|NNP R.|R.|NNP DeSantis|DeSantis|NNP ,|,|, and|and|CC J.|J.|NNP Kuper|Kuper|NNP .|.|. 
2007|2007|CD .|.|. 
Resurgence|resurgence|NN of|of|IN colistin|colistin|NN use|use|NN .|.|. 
Am|be|VBP .|.|. 
J.|J.|NNP Health|Health|NNP Syst|Syst|NNP .|.|. 
Pharm|Pharm|NNP .|.|. 
64:2462|64:2462|CD --|--|: 2466|2466|CD .|.|. 
30|30|CD .|.|. 
Schindler|Schindler|NNP ,|,|, M.|M.|NNP ,|,|, and|and|CC M.|M.|NNP J.|J.|NNP Osborn|Osborn|NNP .|.|. 
1979|1979|CD .|.|. 
Interaction|Interaction|NNP of|of|IN divalent|divalent|JJ cations|cation|NNS and|and|CC polymyxin|polymyxin|NN B|b|NN with|with|IN lipopolysaccharide|lipopolysaccharide|NN .|.|. 
Biochemistry|Biochemistry|NNP 18:4425|18:4425|CD --|--|: 4430|4430|CD .|.|. 
31|31|CD .|.|. 
Schülin|Schülin|NNP ,|,|, T.|T.|NNP 2002|2002|CD .|.|. 
In|in|FW vitro|vitro|FW activity|activity|NN of|of|IN the|the|DT aerosolized|aerosolized|JJ agents|agent|NNS colistin|colistin|NN and|and|CC tobramycin|tobramycin|NN and|and|CC ﬁve|ﬁve|NN intravenous|intravenous|JJ agents|agent|NNS against|against|IN Pseudomonas|Pseudomonas|NNP aeruginosa|aeruginosa|NNP isolated|isolate|VBN from|from|IN cystic|cystic|JJ ﬁbrosis|ﬁbrosis|NN patients|patient|NNS in|in|IN southwestern|southwestern|JJ Germany|Germany|NNP .|.|. 
J.|J.|NNP Antimicrob|Antimicrob|NNP .|.|. 
Chemother|Chemother|NNP .|.|. 
49:403|49:403|CD --|--|: 406|406|CD .|.|. 
32|32|CD .|.|. 
Solá|Solá|NNP ,|,|, M.|M.|NNP ,|,|, F.|F.|NNP X.|X.|NNP Gomis|Gomis|NNP -|-|HYPH Ru|Ru|NNP ̈th|̈th|NN ,|,|, L.|L.|NNP Serrano|Serrano|NNP ,|,|, A.|A.|NNP González|González|NNP ,|,|, and|and|CC M.|M.|NNP Coll|Coll|NNP .|.|. 
1999|1999|CD .|.|. 
Three|three|CD -|-|HYPH dimensional|dimensional|JJ crystal|crystal|JJ structure|structure|NN of|of|IN the|the|DT transcription|transcription|NN factor|factor|NN PhoB|phob|NN receiver|receiver|NN domain|domain|NN .|.|. 
J.|J.|NNP Mol|Mol|NNP .|.|. 
Biol|Biol|NNP .|.|. 
285:675|285:675|CD --|--|: 687|687|CD .|.|. 
33|33|CD .|.|. 
Soncini|Soncini|NNP ,|,|, F.|F.|NNP C.|C.|NNP ,|,|, and|and|CC E.|E.|NNP A.|A.|NNP Groisman|Groisman|NNP .|.|. 
1996|1996|CD .|.|. 
Two|two|CD -|-|HYPH component|component|NN regulatory|regulatory|JJ systems|system|NNS can|can|MD interact|interact|VB to|to|TO process|process|VB multiple|multiple|JJ environmental|environmental|JJ signals|signal|NNS .|.|. 
J.|J.|NNP Bacteriol|Bacteriol|NNP .|.|. 
178:6796|178:6796|CD --|--|: 6801|6801|CD 34|34|CD .|.|. 
Storm|storm|NN ,|,|, D.|D.|NNP R.|R.|NNP ,|,|, K.|K.|NNP S.|S.|NNP Rosenthal|Rosenthal|NNP ,|,|, and|and|CC P.|P.|NNP E.|E.|NNP Swanson|Swanson|NNP .|.|. 
1977|1977|CD .|.|. 
Polymyxin|Polymyxin|NNP and|and|CC related|related|JJ peptide|peptide|NN antibiotics|antibiotic|NNS .|.|. 
Annu|Annu|NNP .|.|. 
Rev.|Rev.|NNP Biochem|Biochem|NNP .|.|. 
46:723|46:723|CD --|--|: 763|763|CD .|.|. 
35|35|CD .|.|. 
Tascini|Tascini|NNP ,|,|, C.|C.|NNP ,|,|, L.|L.|NNP Urbani|Urbani|NNP ,|,|, G.|G.|NNP Biancoﬁore|Biancoﬁore|NNP ,|,|, G.|G.|NNP M.|M.|NNP Rossolini|Rossolini|NNP ,|,|, A.|A.|NNP Leonildi|Leonildi|NNP ,|,|, G.|G.|NNP Gemignani|Gemignani|NNP ,|,|, M.|M.|NNP L.|L.|NNP Bindi|Bindi|NNP ,|,|, C.|C.|NNP Mugnaioli|Mugnaioli|NNP ,|,|, F.|F.|NNP Filipponi|Filipponi|NNP ,|,|, and|and|CC F.|F.|NNP Menichetti|Menichetti|NNP .|.|. 
2008|2008|CD .|.|. 
Colistin|colistin|NN in|in|IN combination|combination|NN with|with|IN rifampin|rifampin|NN and|and|CC imipenem|imipenem|NN for|for|IN treating|treat|VBG a|a|DT blaVIM|blavim|NN -|-|HYPH 1|1|CD metallo|metallo|NN -|-|HYPH beta|beta|NN -|-|HYPH lactamase|lactamase|NN -|-|HYPH producing|produce|VBG Enterobacter|Enterobacter|NNP cloacae|cloaca|NNS disseminated|disseminate|VBD infection|infection|NN in|in|IN a|a|DT liver|liver|NN transplant|transplant|NN patient|patient|NN .|.|. 
Minerva|Minerva|NNP Anestesiol|Anestesiol|NNP .|.|. 
74:47|74:47|CD --|--|: 49|49|CD .|.|. 
36|36|CD .|.|. 
Thiolas|Thiolas|NNP ,|,|, A.|A.|NNP ,|,|, C.|C.|NNP Bollet|Bollet|NNP ,|,|, B.|B.|NNP La|La|NNP Scola|Scola|NNP ,|,|, D.|D.|NNP Raoult|Raoult|NNP ,|,|, and|and|CC J.|J.|NNP M.|M.|NNP Pagés|Pagés|NNP .|.|. 
2005|2005|CD .|.|. 
Successive|successive|JJ emergence|emergence|NN of|of|IN Enterobacter|Enterobacter|NNP aerogenes|aerogene|VBZ strains|strain|NNS resistant|resistant|JJ to|to|IN imipenem|imipenem|NN and|and|CC colistin|colistin|NN in|in|IN a|a|DT patient|patient|NN .|.|. 
Antimicrob|Antimicrob|NNP .|.|. 
Agents|agent|NNS Chemother|Chemother|NNP .|.|. 
49:1354|49:1354|CD --|--|: 1358|1358|CD .|.|. 
37|37|CD .|.|. 
Vaara|Vaara|NNP ,|,|, M.|M.|NNP ,|,|, T.|T.|NNP Vaara|Vaara|NNP ,|,|, and|and|CC M.|M.|NNP Sarvas|Sarvas|NNP .|.|. 
1979|1979|CD .|.|. 
Decreased|decrease|VBN binding|binding|NN of|of|IN polymyxin|polymyxin|NN by|by|IN polymyxin|polymyxin|NN -|-|HYPH resistant|resistant|JJ mutants|mutant|NNS of|of|IN Salmonella|Salmonella|NNP typhimurium|typhimurium|NN .|.|. 
J.|J.|NNP Bacteriol|Bacteriol|NNP .|.|. 
139|139|CD :|:|: 664|664|CD --|--|: 667|667|CD .|.|. 
38|38|CD .|.|. 
Wösten|Wösten|NNP ,|,|, M.|M.|NNP M.|M.|NNP ,|,|, L.|L.|NNP F.|F.|NNP Kox|Kox|NNP ,|,|, S.|S.|NNP Chamnongpol|Chamnongpol|NNP ,|,|, F.|F.|NNP C.|C.|NNP Soncini|Soncini|NNP ,|,|, and|and|CC E.|E.|NNP A.|A.|NNP Groisman|Groisman|NNP .|.|. 
2000|2000|CD .|.|. 
A|a|DT signal|signal|NN transduction|transduction|NN system|system|NN that|that|WDT responds|respond|VBZ to|to|IN extracellular|extracellular|JJ iron|iron|NN .|.|. 
Cell|cell|NN 103:113|103:113|CD --|--|: 125|125|CD 
